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Abstract
New and emerging infectious diseases pose a growing global challenge for patient diagnosis
and treatment, and for public health responses. Biosensors are one of the fastest growing
technologies for in vitro diagnostics, and the sophisticated microsystems offer exciting
opportunities for decentralized clinical applications in medicine and diagnostics. In this
PhD project, low cost electrochemical plastic sensors for basic research, diagnosis of viral
infections or drug discovery were developed and evaluated.
In the developed biosensor chip, early signs of virus infection in cell culture could be
detected electrically using a cell based biosensing platform. The system responded for
the infection of human cells within a few hours. This is a highly competitive time frame
compared to viral culture, which is still the golden standard for laboratory diagnosis of
viral infections.
The biosensing platform was adapted to selectively fish out virions from body fluid by
aptamer functionalization. The intact virus particles were captured by immobilized aptamer
probes on conductive polymer electrodes, allowing fast and easy electrical detection. The
sensor responded rapidly, and showed high sensitivity and specificity. Influenza virus in
saliva specimen was detectable within fifteen minutes at a clinically relevant concentration.
The device has potential for miniaturization into a cost effective field ready point of care
diagnostic system, where the majority of established techniques fail to function outside
the specialized laboratory.
Microfluidic cell migration devices, imitating in vivo conditions were developed with suc-
cess, improving the in vitro experimental setup for basic research and drug discovery.
Polymer biosensors have reached a new level of maturity, and pathogen detection could
benefit from the integration of electrical sensors into low cost plastic microdevices pioneer-
ing point of care testing. The presented biosensing platforms have potential for scaling up
towards high throughput screening, and are adaptable to other applications in medicine
and diagnostics, and other fields.

Resumé
Infektiøse sygdomme udgør en stadig større global udfordring når det kommer til diag-
nostik, behandling og offentlig sundhedspolitik. Biosensorer er en af de hurtigst voksende
teknologier indenfor in vitro diagnostik. De sofistikerede mikrosystemer åbner op for spæn-
dende decentraliserede kliniske anvendelsesmuligheder i medicin og diagnostik. Billige elek-
trokemiske plastiksensorer til grundforskning, diagnostik af virusinfektioner og opdagelse
af nye lægemidler blev udviklet og evalueret i dette ph.d. projekt.
Med en udviklet biosensor chip kunne tidlige tegn på virusinfektion måles elektrisk i
cellekultur. Systemet registrerede en infektion i humane celler indenfor et par timer. Dette
er en betydelig tidsbesparelse i forhold til traditionel viruskultur, som stadig er den gyldne
standard i laboratoriet til diagnosticering af virusinfektioner.
Biosensorplatformen blev tilpasset til selektivt at fiske intakte viruspartikler fra kropsvæske
ved hjælp af overfladefunktionalisering med aptamerer. Viruspartiklerne bandt til aptamer
prober, der var immobiliserede på ledende polymerelektroder, og interaktionen kunne hur-
tigt og let måles elektrisk. Sensoren svarede hurtigt og udviste høj sensitivitet og speci-
ficitet. Klinisk relevante koncentrationer af influenzavirus i spytprøver blev påvist indenfor
femten minutter. Apparatet kan potentielt udformes til et omkostningseffektivt diagnos-
tisk point of care system til brug i felten - et sted hvor de fleste etablerede teknikker
fejler.
Mikrofluide cellemigrationsplatforme - der imiterer in vivo forhold - blev udviklet med
succes. De kan forbedre den eksperimentelle in vitro forsøgsopsætning til grundforskning
og opdagelse af nye lægemidler.
Plastic biosensorer har nået et nyt niveau og medicinsk diagnostik kan drage fordel af
integrering af elektriske sensorer i billige plastik mikrosystemer til påvisning af patogener,
og bane vejen for point of care undersøgelser. De præsenterede platforme kan potentielt
masseproduceres og let tilpasses andre opgaver indenfor området.
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Introduction
In modern medicine and diagnostics, interdisciplinarity is becoming increasingly impor-
tant. This project combined research at the interface between nanotechnology, biology and
medicine, which are important and strong scientific fields in Denmark.
With a background in biomedical engineering, a fascination of cellular mechanisms, and
experience in microfluidic devices for cell migration studies, I was very determined on
exploring the combination of the nano- and polymer technology with electrical sens-
ing techniques to conduct cellular and virological studies. My goal was to improve the
understanding of fundamental biological mechanisms and build a foundation for novel
and innovative - and immensely useful - detection devices for application in medicine and
diagnostics.
The demand in the field of medical diagnostics for simple, cost efficient and disposable
devices is growing, among others attributable to infectious disease being an increasing
cause of morbidity and mortality worldwide. Current diagnostic techniques are inadequate;
labour intensive, expensive, and associated with slow turnaround. Therefore, the main goal
of the PhD project was to develop an impedance based sensor for medical diagnostics of
viral infections to remedy these shortcomings. Impedance based biosensors have lately
been recognized for their high sensitivity, specificity and simplicity, and fast response
time. Evidence point at early identification of emerging pathogens as a key to control and
confine spread of infectious diseases, hence impedance based biosensors have the potential
to become important diagnostic tools with point of care application.
1.1 Outline
The content of this thesis is based on a selection of published and unpublished work
performed during the three year period of my PhD studies. Motivation for the project
and relevant concepts are covered in Chapters 1 and 2. The core results of the project
are presented in manuscripts and papers listed in Section 1.2 and included in Chapter 3
2 Introduction
and Chapters 5–7. These chapters are structured with a short introduction to the article,
and a concluding remark subsequent to the article. Selected side projects are collected in
Chapter 4 and Chapter 8. A review of the project is given in Chapter 9, and the the PhD
project is summarized in Chapter 10, with conclusions and outlook.
Chapter 2: Basic Concepts
Short general introduction to relevant background subjects.
Chapter 3: Aptamer Based Biosensor
Electrical detection of intact virus particles.
The work is presented in the form of a publication.
Chapter 4: Nanowire Based Biosensor
Electrical sensing of single cells.
Preliminary results are presented.
Chapter 5: Cell Based Biosensor: Review
Review of cell based biosensors.
The work is presented in the form of a publication.
Chapter 6: Cell Based Biosensor: Detection of Virus
Electrical and visual detection of the immediate cellular response to virus challenge.
The work is presented in the form of a publication.
Chapter 7: Cell Migration in Microfluidic Device
On-chip cell migration assay for studies of leukocyte homing.
The work is presented in the form of a publication.
Chapter 8: Impedimetric Detection of Cell Migration
On-chip cell migration assay for studies of wound healing.
Preliminary results are presented.
Chapter 9: Project Review
Summary of PhD project with objective and goal.
Chapter 10: Conclusion and Perspectives
General conclusion.
1.2 Publications
The following lists summarize the scientific first and co-author work of the PhD study in
terms of papers and manuscripts for peer reviewed journals and conference proceedings.
Papers and manuscripts have status of either published or accepted.
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1.2.1 Manuscripts and Papers for Peer Reviewed Journals
1. K. Kiilerich-Pedersen, J. Dapra, S. Cherre and N. Rozlosnik. High Sensitivity
Point-of-Care Device for Direct Virus Diagnostics, Biosensors and Bioelectronics,
accepted, April 2013.
2. G.M. Hjortø, K. Kiilerich-Pedersen, D. Selmeczi, T.N. Kledal, and N.B. Larsen.
The human CMV chemokine receptor US28 induces migration of cells on a CX3CL1-
presenting surface, Journal of General Virology, accepted, January 2013.
3. K. Kiilerich-Pedersen and N. Rozlosnik. Cell Based biosensors: Electrical Sensing
in Microfluidic Devices, Diagnostics, 2(4):83-96, 2012.
4. J. Dapra, K. Kiilerich-Pedersen, N.O. Christiansen, C.R. Poulsen, and N. Roz-
losnik. Conductive Polymers in Medical Diagnostics, Nanomedicine in Diagnostics,
Science Publishers, Chapter 5, 2012.
5. K. Kiilerich-Pedersen, C.R. Poulsen, J. Dapra, N.O. Christiansen, and N. Rozlos-
nik. Polymer Based Biosensors for Pathogen Diagnostics, Environmental Biosensors,
InTech, Chapter 9, 2011.
6. K. Kiilerich-Pedersen, C.R. Poulsen, T. Jain, and N. Rozlosnik. Polymer based
biosensor for rapid electrochemical detection of virus infection of human cells, Biosen-
sors and Bioelectronics, 28(1):386-392, 2011.
7. D. Kwasny, K. Kiilerich-Pedersen, J.L. Moresco, M. Dimaki, N. Rozlosnik, and
W.E. Svendsen. Microfluidic device to study cell transmigration under physiological
shear stress conditions, Biomedical Microdevices, 13(5):899-907, 2011.
1.2.2 Conferences
1. K. Kiilerich-Pedersen and N. Rozlosnik. All polymer sensor for pathogen detec-
tion, Oral Presentation, AnalytiX2013, Suzhou, China, 2013.
2. K. Kiilerich-Pedersen, C.R. Poulsen, T. Jain, and N. Rozlosnik. Polymer Based
Biosensor for Rapid Electrochemical Detection of Virus Infection in Human Cells,
Poster Presentation, CLINAM, Basel, Switzerland, 2012.
3. D. Kwasny, K. Kiilerich-Pedersen, J.L. Moresco, M. Dimaki, N. Rozlosnik, and
W.E. Svendsen. Microfluidic device as a novel cell transmigration assay, Poster Pre-
sentation, NanoBioTech Conference, Montreux, Switzerland, 2011.
4. K. Kiilerich-Hansen, C.R. Poulsen and N. Rozlosnik. Polymer Based Biosen-
sor for Rapid Electrochemical Detection of Human Cytomegalovirus Infection in
Human Fibroblast Cells, Poster Presentation, ESF-UB Conference in Biomedicine:
Nanomedicine: Reality Now and Soon, San Feliu, Spain, 2010.
4 Introduction
5. N. Rozlosnik, K. Kiilerich-Pedersen, and J. Dapra. Advances in Virus detec-
tion: Functionalized and Micropaterned Microfluidic Systems, Poster Presentation,
NanoMedicine 2010, Beijing, China, 2010.
6. K. Kiilerich-Pedersen, G.M. Hjortø, and T.N. Kledal. Microfluidic Device for
Studies of Haptotactic Cell Migration, Poster Presentation, COMS, Copenhagen,
Denmark, 2009.
Chapter 2
Basic Concepts
This chapter provides a general introduction to the main subjects of this thesis: Impedance
based biosensors for medical diagnosis of acute viral disease. Emerging and re-emerging
infectious diseases are introduced in Section 2.1 - they are a source of worry to the world
population, because they may cause severe illness and death, and can spread very rapidly.
Early and precise identification of flourishing pathogens is vital for proper disease manage-
ment. Section 2.2 introduces the concept of point of care. It is an emerging field within
medical diagnostics and disease monitoring, and the technological advancements in the
biosensor technology have lately accelerated research and development in point of care.
Impedance based biosensors are presented in Section 2.3, followed by a brief description of
the microfluidic system employed in this PhD study in Section 2.4. Section 2.5 introduces
the biosensors employed in this thesis, and the chapter is wrapped up in Section 2.6 with
a concluding remark.
2.1 Emerging Diseases
Millions of people are dying every year from diseases that are well understood, preventable,
and treatable [1]. Environmental changes and increased global travel to remote regions of
the developing world have exposed people to disease vectors that had not previously been
encountered. Remote regions with inadequate healthcare are not equipped to handle dis-
eases that are well known and preventable in other parts of the world, and the developed
world is not immune to the diseases endemic to these remote regions. Therefore disease
diagnosis, treatment and surveillance in the developing countries is of worldwide pub-
lic health interest. Diagnosis of infectious disease currently requires extensive laboratory
facilities, leaving many people undiagnosed in developing areas of the world.
Emerging and re-emerging diseases, combined with the rapid spread of pathogens resis-
tant to antibiotics and of disease-carrying insects resistant to insecticides are a daunting
challenge to human health.
6 Basic Concepts
Studies show that pandemics of new strains of influenza and other emerging diseases are
travelling faster and wider than ever before owing to the global travel and trade [2]. Novel
diseases such as Ebola, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and
hepatitis C are still incurable. They represent a significant cause of suffering and death, and
impose an enormous financial burden on society. Some older diseases have been effectively
controlled by vaccination programs and antibiotics, whereas well known diseases such as
malaria and tuberculosis are re-emerging in antimicrobial resistant forms [2]. Figure 2.1
provides a global overview of emerging and re-emerging infectious diseases.
Pathogens are ubiquitous in the human environment and can cause disease in humans and
animals. Viruses are a unique class of infectious agents which are extremely small, contain
only one type of nucleic acid and have an absolute dependence on living cells for replication.
Due to the limited genomic composition, viruses need host cell organelles, enzymes and
other macromolecules for multiplication - and the effects of multiplication range from
minor changes in the metabolism to cytolysis. Like other pathogens, virus populations
continually evolve. As an example, influenza virus is a segmented RNA virus, hence new
subtypes emerge periodically as a result of point mutations and genetic reassortment [3].
Some new strains are harmless whereas others can be highly pathogenic to humans and
animals, therefore influenza will continue to be a major concern around the globe.
The most common tools applied for pathogen detection are polymerase chain reaction, cell
culture and immunology based assays. These methods are well established and character-
ized by high sensitivity and specificity, and in particular yield robust results when used in
Figure 2.1: Global examples of emerging (red) and re-emerging (blue) infectious diseases.
Adapted from [1].
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combination [4]. Despite these qualities, the conventional techniques are labour intensive,
expensive and associated with long turnover times. This is clearly insufficient, and efforts
are being made in the development of new advanced tools for pathogen detection.
2.2 Point of Care
Point of care diagnostic systems are miniaturized devices designed to be inexpensive,
portable, and field ready with high sensitivity and specificity. The concept of point of
care testing was first introduced in the 1960’s with urine sample analysis and glucose
testing.
The new generation of point of care systems combines convenience and fast turnaround
time with the reliability of laboratory testing, further driving the course towards patient
side testing. The trend towards point of care diagnostics is an evolutionary change, where
the decentralization of laboratory testing is an extension of the current laboratory services.
Point of care systems could prevent unnecessary delays in critical therapeutic decisions, or
provide more convenient patient management methods for both the healthcare provider
and patient.
These systems could revolutionize healthcare in developing countries where the need for
small and low cost medical solutions is ever increasing, and potentially reach populations
in remote regions of the world where lack of infrastructure until now has hindered diagnosis
and analysis of emerging infectious diseases.
2.3 Electrochemical Biosensors
Biosensors are analytical devices based on biological recognition elements, allowing for the
development of point of care diagnostic tools by integrating them into closed microfluidic
systems. The working principle of a biosensor is illustrated in Figure 2.2. Many different
combinations of biological probes and transducing technologies have been developed and
demonstrated throughout the years.
Figure 2.2: Schematic representation of a biosensor with the different components; analyte,
biological recognition element, transducer, and the electrical signal originating from the
biorecognition event.
8 Basic Concepts
Electrochemical biosensors constitute a large group of sensors transforming a chemical
reaction or process into an electrical signal. Impedimetric biosensors belong to this class,
and they have recently attracted attention for the high sensitivity, reliability and simpli-
city [5–10]. Moreover, impedimetric sensors are user friendly, cost effective and in many
cases disposable, hence suitable for portable point of care systems. Miniaturization of
electrochemical instrumentation to small pocket size devices has played an important role
in the transition towards simplified testing for home usage.
2.3.1 Impedimetric Biosensors
Electrochemical impedance spectroscopy is a powerful tool for label free analysis of inter-
facial phenomena, providing detailed information on the changes in capacitance and resis-
tance originating from biorecognition events at conductive surfaces. The impedance of a
system is measured in real time by applying a small amplitude alternate current electric
field, and the phase difference of the concomitant electrical potential that develops across
it is measured. Since the impedance readout is an electrical signal, the risk of misinter-
preting results is eliminated. Impedance signals can be correlated with standard levels,
and quantification of data is attainable through calibration.
Impedance spectra are typically presented in the form of a Nyquist plot, where the imagi-
nary component ZIm is plotted against the real component ZRe (Figure 2.3). The semicircle
at the higher frequencies corresponds to the electron transfer limited processes, and the
diffusion limited electrochemical processes at the lower frequencies are represented in the
linear part of the spectrum. The frequency response of a system can be illustrated in a
Bode plot (Figure 2.3).
The impedance technology is non invasive and enables analysis of small interfacial changes
originating from a biorecognition event at an electrode surface. The technique is very
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Figure 2.3: Examples of Nyquist and Bode plots. Z is the impedance.
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sensitive and when combined in a microfluidic system, low concentrations of a target
analyte is detectable.
Electrochemical sensors based on cells, antibodies or aptamers offer great selectivity and
sensitivity for early diagnostics of cancer, autoimmune disorders or infectious diseases.
2.3.2 Note on Optical Detection
While impedimetric sensors are receiving much attention, there are other attractive trans-
ducing technologies with promising application in medicine and diagnostics.
Optical detection techniques - employing fluorescent markers or colored additive - com-
prise a category of biosensors with application within this field. Related methods are
surface plasmon resonance and surface enhanced Raman spectroscopy. Applications for
these techniques range from a simple laminar flow assay as found in pregnancy tests to
high technological solution like DNA microarrays. Some argue that optical detection pro-
vide a higher sensitivity than electrochemical detection methods, however, the cost and
complexity of optical sensors make them unattractive.
Cost efficiency is an important consideration in the development of biosensors. Micro-
fabrication techniques have enabled downscaling of systems, leading to improved mixing
rates and mass transport phenomena in microfluidic channels. As a results, analysis time
and sample consumption have been significantly lowered, and so has the cost. Another
benefit of low biological sample volumes is the increased safety associated with device
handling.
2.4 Design of Biosensor
Polymer based microfluidic systems meet the requirements of disposable devices for low
sample consumption, cost efficiency, reliability, and fast response time, which make the
systems ideal for point of care analysis. Microfluidic channels offer a very controlled envi-
ronment, providing a suitable platform for cellular studies or investigations of biochemical
and biophysical events. An all polymer microsystem (Figure 2.4) was designed and fa-
bricated in Topas® with interdigitated microelectrodes in conductive polymer PEDOT
or PEDOT-OH doped with tosylate (PEDOT:TsO or PEDOT-OH:TsO). The fabrication
process was continuously optimized; refer to Chapter 3 and Chapter 6 for detailed proce-
dures.
In brief, top and bottom plastic parts were fabricated in Topas® by injection molding [11],
while microchannels were defined in adhesive tape by laser ablation. Conductive polymer
electrodes and electrical connection patches were either patterned in cleanroom using
standard photolitographic processing techniques, or in a general laboratory by agarose
stamping [12]. The final chip was bonded in a computer controlled press.
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Figure 2.4: (a) All polymer microdevice with two functional channels fabricated in Topas®
(transparent) and PEDOT:TsO (blue), (b) microchannel with an interdigitated micro-
electrode array. Adapted from [13].
2.4.1 Conductive Polymer Electrodes
There is an extensive pool of materials available when producing polymer based micro-
fluidic systems. The conductive polymer PEDOT was selected for its high conductivity
and environmental stability, biocompatibility, transparency to visible light and ease of
processing [14]. Doping PEDOT with tosylate yields superior quality in phosphate buffers
and high conductivity [15,16].
Conductive polymers have the potential to replace metals and semiconductors as elec-
trode materials; a long term stability of PEDOT has been demonstrated in aqueous so-
lutions [17, 18]. Conductive polymers have the advantageous properties of inexpensive
electrode fabrication and easy electrode functionalization [14]. This feature is of great im-
portance in biosensor applications, where particles or cells are immobilized directly on the
electrode surface.
The unique characteristics of PEDOT make the material particularly suited for use in
biomedical devices and cell based assays. PEDOT is known for having great cell com-
patibility and is increasingly being used for handling, analyzing and culturing of living
cells [19–25]. Here, PEDOT microelectrodes were employed in studies of cell development
over time through impedance spectroscopy [13].
2.4.2 Cell Compatibility
Cells are very sensitive and respond immediately to environmental changes, thus it is
of great importance that the cell compatibility of medical devices for both short and
long term usage is evaluated. Material characteristics that affect cell compatibility are
inertness, hydrophilicity and roughness. Materials used for the fabrication of microdevices
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were investigated independently, and the compatibility of the all polymer microdevices
were further evaluated by culturing human cells in chips for a week. The cells adhered
and proliferated normally on Topas® and PEDOT:TsO, and no significant change in the
morphology of cells could be observed during this period (Figure 2.5). The conducting
polymer material PEDOT-OH:TsO also demonstrated excellent cell compatibility, similar
to PEDOT:TsO [13].
Figure 2.5: Cell compatibility of an all polymer microchip was evaluated by culturing
human cells for a week. Cells were seeded on the conductive polymer microelectrodes in a
microfluidic channel at low density. The cells adhered and proliferated normally on Topas®
and PEDOT:TsO, and no significant change in the morphology of cells could be observed
during the period. On the sixth day, cells were exposed to a flow at a high rate to decrease
the number of cells. Adapted from [13].
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2.5 Biosensors Used in This Thesis
Biosensors are composed of two elements; a sensor and a detector. Impedimetric sensors
were introduced in Section 2.3.1; this mode of transduction was employed throughout the
PhD project in combination with different sensing elements. The biosensors described in
this thesis are classified according to the recognition elements, and the following sections
provide shorts introductions to the different types of sensors.
2.5.1 Aptamer Based Biosensor
The use of aptamers as recognition elements in sensors is gaining increased popularity,
and they are now recognized as substitutes for antibodies on the diagnostic front [27]. The
short nucleotide sequences with specific binding capabilities are generated in vitro from a
randomized pool of molecules by affinity and amplification processes [28]. Aptamers are
generated with a high degree of control, giving a more consistent quality than antibodies,
which are produced in a biological system, with a batch to batch variation and much
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Figure 2.6: Example of an aptamer based biosensor for impedimetric detection of in-
fluenza virus in saliva. Aptamers with affinity for the virus were immobilized on conductive
polymer microelectrodes, and a baseline in saliva was recorded. Sample was introduced
around minute 7, and aptamer-virus complex formation induced an increase in the ab-
solute impedance. Detection of influenza virus in saliva (circle, red trace) and control
measurement in saliva (triangle, black trace). The outliers around minute 7 originate from
the disturbances caused by sample injection. Adapted from [26].
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shorter shelf life. Unlike most monoclonal antibodies, an aptamer binds highly specific to
its target, and can be designed to discriminate between virus strains for a specific virus
subtype, based on differences in the amino acid residues [27,29].
Immobilization of aptamers on a microelectrode array provokes an increase in the impedance
due to higher charge transfer resistance at the electrode/liquid interface, and the binding
of target molecule to aptamers further cause an increase in the impedance (Figure 2.6).
The complex formation perturbs the charged double layer at the interface, and the in-
creased thickness and insulation of the surface gives rise to an increase in capacitance
and resistance. Saturation is reached when the conductive surface is entirely covered with
complexes.
An example of an aptamer based biosensor is given in Chapter 3.
2.5.2 Nanowire Based Biosensor
Nanostructures offer intriguing opportunities for developing novel biosensing platforms [31],
and the field of silicon nanowires has been extensively investigated since the original pa-
per was published more than a decade ago [32]. Nanowires have primarily been used as
electrical detectors, in a simple design that allows for development of compact point of
care devices. The large surface to volume ratio produces an extremely high sensitivity -
ultimately a promise for single molecule detection. Although the technology is attractive,
the cost is a challenge hindering full exploration of nanowire microdevices as biosensors in
medicine and diagnostics [33]. Processing costs are significantly reduced with the use of
conductive polymer nanowires [34–36] combined with a new and fast fabrication procedure
exploiting the properties of self assembled peptide nanotubes [30].
Conductive polymer nanowires were fabricated by combining bottom up fabrication with
standard cleanroom processing techniques. The conductive polymer was spun onto a sub-
strate containing gold contact patches, and patterned into nanowires using self organizing
Figure 2.7: Conductive polymer (PEDOT-OH:TsO) nanowire; (a) scanning electron mi-
croscopy image of nanowire spanning between gold contact patches [30], (b) atomic force
microscopy topography image of nanowire spanning between gold contact pads, and (c)
microscopy image of human cell on a nanowire.
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peptide nanotubes as dry etching mask. The nanotubes remained stable during etching,
and were dissolved in water afterwards [30].
Figure 2.7 show a scanning electron microscopy image, an atomic force microscopy topo-
graphy image, and a microscopy image of a conductive polymer (PEDOT-OH:TsO) nano-
wire spanning between gold contact pads, respectively. The surface roughness of the nano-
wire induces a larger surface to volume ratio than comparable flat nanowires and increases
the sensitivity of measurements.
Single cell detection and analysis is essential for an accurate and profound comprehension
of cell behaviour. Different assays for single cell analysis have been proposed [37–40], of
which many require some sort of labeling. Silicon nanowire sensors were employed to
detect the neuronal signal of a single neuron cell and muscle cell [31,41]. Due to alignment
difficulties and low yield of production, only few cell detection studies have been conducted
using silicon nanowires. Easy handling and processing of polymer nanowires make them
suitable for single cell detection. In Figure 2.7(c), a living cell was immobilized on a
conductive polymer nanowire in a microfluidic channel.
An example of a nanowire based biosensor is given in Chapter 4.
2.5.3 Cell Based Biosensor
Cell based biosensors are sophisticated devices, employing immobilized living cells as sens-
ing elements. Cells are by nature very sensitive to changes in the environment, allowing
for physiologically relevant studies of the cellular response to one or more compounds, or
effects.
Among cell based assays, electrochemical impedance spectroscopy combined with micro-
electrode arrays provide a platform for label free detection of the cellular response to
different drugs or pathogens [42, 43]. The interaction between a cell monolayer and the
electrode surface can be monitored in real time by applying a small amplitude alternate
current electric field. Cells are essentially non conducting at low frequencies and the cell
membrane offers a significant barrier to current flow, so that the amplitude of the alter-
nate current field is an indication of the cell volume or size [44]. Average alterations in
the three dimensional shape of cells is then computed by integrating over a monolayer of
hundreds or thousands of cells. The measured impedance reflects changes in the attach-
ment and morphology of cells, and reaches its maximum when the electrode is completely
covered [45,46].
Impedance measured on cells cultured on microelectrodes is very sensitive to small changes
in the cell membrane capacitance and resistance. These parameters are good indicators for
the well being of cells at a given cell morphology. The real time detection of cell impedance
gives an efficient and rapid technique for non invasive monitoring of the response of human
cells in culture to the challenge of a virus infection [47,48].
In general, viral infections can induce degenerative morphological changes in cell cultures;
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Figure 2.8: Actin cytoskeleton of human fibroblast cells stained with Phalloidin.
cell detachment from substrate, release of cell-cell adhesions, cell round up and eventually
cell death. Beside the morphological effects, these changes in the cells produce a decline in
the resistance and an increase in the capacitance in the impedance signal [47,48].
Cell based biosensors are reviewed in Chapter 5, and an example of a cell based biosensor
for virus detection is given in Chapter 6.
2.5.4 Cell Migration
Cell migration refer to the processes involving the translation of cells from one location
to another. Cells migrate in response to multiple situations, and the mode of migration is
highly cell type dependent. Immune cells are nimble, fast moving and rapid turning cells
with a slightly disorganized cytoskeleton, whereas fibroblast cells - at the other end of the
spectrum - have elaborated cytoskeleton structures and generally move slowly (Figure 2.8).
Cells have different characteristics, and contribute to maintain homeostasis.
The process of cell migration plays a vital role in a variety of physiological and pathological
processes. Wound repair and inflammation are examples of two homeostatic processes in
the body that rely on the ability of cells to migrate. Neither of these processes would be
possible if it were not for cell migration, and often they occur together.
An example of a microfluidic device for studies of leukocyte homing is given in Chapter 7,
and preliminary work on a microfluidic system for electrical detection of wound healing is
presented in Chapter 8.
2.6 Concluding Remarks
Design and development of biosensing platforms for medicine and diagnostics require a
coordinated team work across several research fields. This chapter gave a general intro-
duction to the basic concepts, and provided a context for the research results presented in
the thesis.

Chapter 3
Aptamer Based Biosensor
3.1 Introduction
New and emerging infectious diseases pose a growing global challenge for patient diagnosis
and treatment, and for public health responses. In the beginning of 2009, a novel influenza
A (H1N1) virus of swine origin caused human infection and acute respiratory illness in
Mexico. After spreading among persons in the United States and Canada, it spread glo-
bally, resulting in the first pandemic since 1968 with circulation outside the usual influenza
season in the Northern Hemisphere. By March 2010, almost all countries had reported cases
and many laboratory confirmed deaths had been reported to the World Health Organiza-
tion (WHO) [49]. The 2009 influenza pandemic is an example of a zoonotic infection, and
most emerging infectious disease events are caused by zoonotic pathogens.
There are different strategies to manage influenza infections and currently, vaccination is
the primary method for preventing illness. Antiviral treatment is available for influenza
infections, however treatment must be initiated within 36 -48 hours of onset of symptoms
for it to be efficient [50].
The reference standards for laboratory confirmation of acute virus infection are molecular
detection techniques or viral culture. Unfortunately, the results of these assays are ge-
nerally not available within this narrow therapeutic window. Hence, there is a need for
new diagnostic tools with high sensitivity that can deliver a result in a clinically relevant
time frame.
The next generation of point of care devices are simple and inexpensive instruments al-
lowing the untrained user to perform simple diagnostic analyses without the need for a
specialized laboratory.
In this paper, we present a new fast and reliable point of care method for virus diagnostics,
using influenza A virus as an example to demonstrate its usability. A low cost all polymer
microfluidic system was fabricated in Topas® by injection molding and conductive polymer
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(PEDOT-OH:TsO) microelectrodes were patterned by agarose stamping. The electrodes
were functionalized with specific aptamers, and the microchip was exploited for real time
and label free electrical detection of intact virus particles.
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Abstract
Influenza infections are associated with high morbidity and mortality, carry the risk of pandemics, and pose a considerable economic
burden worldwide. To improve the management of the illness, it is essential with accurate and fast point-of-care diagnostic tools for
use in the field or at the patient’s bedside. Conventional diagnostic methods are time consuming, expensive and requires specialized
laboratory facilities. We present a highly sensitive, highly specific, and low cost platform to test for acute virus infections in less
than 15 minutes, employing influenza A virus (H1N1) as an example of its usability. An all polymer microfluidic system with a
functionalized conductive polymer (PEDOT-OH:TsO) microelectrode array was developed and exploited for label free and real time
electrochemical detection of intact influenza A virus (H1N1) particles. DNA aptamers with affinity for influenza A virus (H1N1)
were linked covalently to the conductive polymer microelectrodes in the microfluidic channel. Based on changes in the impedance
when virions were captured by immobilized probes, we could detect clinically relevant concentrations of influenza A virus (H1N1)
in saliva. This is a new, stable and very sensitive point-of-care platform for detection and diagnostics of intact virus particles.
Keywords: Conductive polymer, PEDOT-OH:TsO, electrochemical impedance spectroscopy (EIS), DNA aptamer, influenza A
virus (H1N1), AFM, point-of-care (POC)
1. Introduction1
Influenza infections are a major cause of morbidity and mor-2
tality, even though the vast majority of infections exhibit a self3
limited, acute illness. In the United States alone, influenza in-4
fections pose a considerable economic burden with more than5
200,000 hospitalizations and an average of 36,000 deceased6
of influenza-related causes every year (Thompson et al., 2003,7
2004). Influenza A virus has the potential to generate global8
pandemics, illustrated by the influenza A virus (H1N1) 20099
pandemic, which affected more than 214 countries and was re-10
sponsible for more than 18,000 deaths (Taubenberger and Kash,11
2010).12
Early identification of influenza as the cause of a respiratory13
illness is important for optimal patient management by allowing14
timely administration of antiviral treatment if needed. Current15
antiviral treatments for influenza have been shown to be effec-16
tive in reducing severity, duration of illness and complications,17
but they should be started within 48 hours after onset of symp-18
toms (Nicholson et al.; Treanor et al., 2000).19
The reference standards for laboratory confirmation of in-20
fluenza virus infection are reverse transcription-polymerase21
chain reaction (RT-PCR), direct antigen detection through fluo-22
rescent antibody staining, or viral culture. Viral culture requires23
3 − 10 days, hence is not useful for patient management. Using24
the conventional immunofluorescence test to identify influenza25
antigens in clinical specimens produce a results in 2 − 4 hours,26
however this test depends heavily on laboratory expertise.27
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Molecular biological techniques for genome detection are in-28
creasingly being used in clinical settings, and they can iden-29
tify subtypes of the influenza A virus within 3 − 8 hours in an30
advanced laboratory setup. RT-PCR and other molecular de-31
tection methods are attractive, because they have high sensi-32
tivity and specificity. However, these methods do not indicate33
the viability of virus or on-going viral replication, and more-34
over, these methods are expensive, time consuming and require35
well equipped laboratories and trained personnel. RT-PCR is36
also associated with multiple potential technical errors, includ-37
ing failed extractions and problems with PCR inhibition (Bustin38
and Mueller, 2005).39
To improve the management of influenza infections and virus40
infections in general, it is essential to provide accurate and41
timely point-of-care (POC) diagnostic tools for use in general42
practice or at the patients bedside. Currently, there are a num-43
ber of POC tests available on the market to diagnose influenza44
A virus (H1N1) in clinical specimens, unfortunately these tests45
have demonstrated poor sensitivity and specificity (Babin et al.,46
2011; Bai et al., 2012; Gavin and Thomson, 2004), and incon-47
sistent accuracy (Harper et al., 2009; Chartrand et al., 2012).48
To compete with and outmatch the conventional techniques49
in virus diagnostics, the new generation of POC sensing de-50
vices must fulfil high standards and be producible at reasonable51
cost (Price and Kricka, 2007). Polymer based microfluidic sys-52
tems meet the requirements of disposable devices, low sample53
consumption, cost efficiency, reliability, and fast response time,54
hence making the systems ideal for POC analysis. By selecting55
conducting polymers as electrode materials, the additional ad-56
vantageous properties of inexpensive electrode fabrication and57
easy electrode functionalization can be achieved (Rozlosnik,58
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2009).59
Seasonal influenza A virus spread via respiratory secretions,60
and virus is shed in various specimens from the upper respira-61
tory tract, such as nasal secretions or saliva specimens (Robin-62
son et al., 2008). Nasal secretions are generally preferred due to63
high numbers of infected cells, which is important for conven-64
tional molecular diagnostic techniques. Saliva specimens are65
easily obtained but the virus concentration is lower (Robinson66
et al., 2008). However, utilizing a highly sensitive and highly67
specific POC device would neither require the presence of cells68
nor a high concentration of virus, consequently diagnosing in-69
fluenza based on a saliva specimen would suddenly be doable.70
We introduce a highly sensitive, highly specific, and very71
cheap method to test for acute virus infections in less than72
15 minutes, using influenza A virus as an example. An all73
polymer microsystem with a functionalized conductive poly-74
mer (PEDOT-OH:TsO) microelectrode array was exploited for75
label free and real time electrochemical detection of intact in-76
fluenza A virus (H1N1) particles. DNA aptamers with affinity77
for influenza A virus (H1N1) were linked covalently to the con-78
ductive polymer microelectrodes in the microfluidic channel.79
Based on changes in the electrical signal at the electrode sur-80
face when virus particles were captured by specific aptamers,81
we could detect clinically relevant concentrations of intact in-82
fluenza A virus (H1N1). This is an new, stable and very sensi-83
tive platform for virus detection and diagnostics. In this system,84
intact virus is detected and quantified in its native configuration85
without destructing the particles, which is an advantage com-86
pared to RT-PCR.87
2. Experimental Procedures88
2.1. All polymer microsystem89
The all polymer microfluidic device has previously been de-90
scribed (Kiilerich-Pedersen et al., 2011). In brief, top and91
bottom pieces were fabricated from the cyclic olefin copoly-92
mer TOPAS 5013L (TOPAS Advanced Polymers, Germany;93
Tg ' 134 ◦C) by injection moulding (Victory 80/45 Tech, En-94
gel, Germany). The top part contained access ports in standard95
luer lock size for fluid inlets, outlets and electrical connections.96
The second layer - microchannels and reservoirs - were defined97
in a 150 µm thick, pressure sensitive adhesive (PSA, ARcare98
90106, Adhesive Research, USA) by laser ablation (Duo Laser99
CO2 laser, Synrad Inc, USA). Electrodes and electrical connec-100
tion patches in the third layer were patterned in the conductive101
polymers, poly(3,4-ethylenedioxythiophene) doped with tosy-102
late (PEDOT:TsO) and ((2,3-dihydrothieno[3,4-b][1,4]-dioxin-103
2-yl)methanol) (PEDOT-OH:TsO) using agarose stamping, de-104
scribed in detail by Dapra` et al. (Dapra` et al., 2013). The final105
chip was assembled by thermal assisted bonding at 75 ◦C with106
500 N force applied for 5 minutes in an in house build, LabView107
(National Instruments, USA) controlled press. In an assembled108
device, the volume of the microchannel was 100 µL.109
2.2. Oligonucleotides110
An oligonucleotide with the following sequence was used in111
this study: 5’AAT TAA CCC TCA CTA AAG GGC TGA GTC112
TCA AAA CCG CAA TAC ACT GGT TGT ATG GTC GAA113
TAA GTT AA-3 (A22 presented by Jeon et al. (2004)) (DNA114
Technology A/S, Denmark). The molecule was functionalized115
with an 5’-amino modified C6 linker.116
2.3. Virus117
Influenza A virus (H1N1, strain A/PR/8/34, ATCC Cat. No.118
VR-1469; LOT:59252244) was aliquoted and stored at −80 ◦C.119
2.4. Electrode Functionalization120
Succinic acid was grafted onto surface hydrox-121
ymethyl groups with 0.1 M MES buffer (2-(N-122
morpholino)ethanesulfonic acid) at pH 4.0 supplemented123
with 50 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide124
(EDC) and 50 mM succinic anhydride for 20 minutes at room125
temperature. Following, the surface carboxylic acid groups126
were activated with 50 mM EDC and 40 mM NHS (N-hydroxy127
succinimide) in MES buffer (0.1 M, pH=4.0) for 5 minutes.128
The microchannel was washed with MES buffer (0.1 M,129
pH=4.0), and then the activated acid intermediate reacted with130
the 5’amino group of the aptamer at a concentration of 100 nM131
in water to form a stable amide bond. Reaction was allowed to132
proceed over night and then the microchannel was rinsed with133
PBS.134
2.5. Electrochemical Measurements135
Electrochemical impedance measurements were employed to136
detect influenza A virus (H1N1) in PBS or saliva. Electrochem-137
ical impedance measurements were recorded every 33 s in the138
frequency range from 0.2 Hz to 10 kHz with an amplitude of139
10 mV in a two electrode setup. The optimal frequency for the140
analysis was found at 251 mHz. It was determined by the high-141
est response to virus binding on electrodes, taking into consid-142
eration the best signal-to-noise ratio and the measurement time.143
This frequency was used for all analyses.144
For characterization of the sensor, all measurements were145
carried out in stationary (no flow) conditions. A baseline was146
recorded in PBS (no analyte), and then increasing concen-147
trations of influenza A virus (10 -106 pfu/mL) in PBS were148
introduced every 20 minutes. Afterwards, the microchannel149
was rinsed with PBS and spectra were recorded for additional150
20 minutes. The final step served as a control to ensure that151
virus was immobilized.152
To test the usability of the sensor in a more realistic setting,153
saliva was spiked with influenza A virus (H1N1). A baseline154
was recorded in saliva diluted 1:10 in PBS. Saliva used for the155
initial baseline measurements had been boiled to prevent degra-156
dation of the ssDNA aptamer. Samples containing influenza A157
virus (H1N1) at a concentration of 103 pfu/mL in saliva diluted158
1:10 in PBS were introduced at t=1 hour, and control measure-159
ments were conducted in saliva diluted 1:10 in PBS.160
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2.6. Atomic Force Microscopy (AFM) Imaging of Virus161
TOPAS 5013L discs patterned with conductive polymer162
(PEDOT-OH:TsO) electrodes were employed for AFM exam-163
inations. Electrodes on discs were functionalized with ss-164
DNA A22 (except negative controls) according to the proce-165
dure described in Section 2.4, and virus at a concentration of166
105 pfu/mL in PBS was allowed to bind for 20 minutes. Discs167
were then washed three times with PBS to remove residual168
virus, fixed in 2.5 % glutaraldehyde in PBS for 60 minutes at169
room temperature, and washed with PBS for 15 minutes at170
4 ◦C. Samples were dehydrated by increasing concentrations171
of ethanol (30 -99 %) for 10 minutes at room temperature and172
allowed to air dry over night. AFM images were recorded with173
a XE150 (Park Systems, Korea) in tapping mode using non con-174
tact high frequency cantilever (BS-Tap300AI, Budget Sensors,175
Bulgaria) with a force constant of 40 N/m. Examinations were176
carried out in air at room temperature.177
3. Results and Discussion178
We present a new fast and reliable POC method for virus di-179
agnostics, and employ influenza A virus (H1N1) as an example180
to demonstrate its usability. A low cost all polymer microflu-181
idic system with functionalized interdigitated conductive poly-182
mer microelectrodes was exploited for real time and label free183
detection of intact virus particles.184
3.1. Aptamers185
Aptamers are nucleic acid ligands, generated in vitro from186
a randomized pool of molecules by affinity and amplification187
processes (?). DNA aptamers were employed in this study due188
to the advantageous properties over antibodies, and because ap-189
tamers are now recognized as substitutes for antibodies on the190
diagnostic front (Gopinath, 2007). Aptamers are generated with191
a high degree of control, giving a more consistent quality than192
antibodies, which are produced in a biological system, with a193
batch to batch variation and much shorter shelf life.194
The applied ssDNA aptamer A22 with binding capacity to195
intact influenza A virus (H1N1) binds directly to the globu-196
lar region of the influenza glycoprotein hemagglutinin (HA)197
(HA-(91-261)) (Jeon et al., 2004). Unlike most monoclonal198
antibodies, the aptamer A22 binds highly specific to its tar-199
get, and can discriminate between virus strains within the200
influenza subtypes, based on differences in the amino acid201
residues (Gopinath, 2007).202
The aptamers were covalently linked to conductive polymer203
microelectrodes with the 5’-amino modified C6 linker, and a204
homogeneous distribution of aptamers on the microelectrode205
surface was achieved (see on Figure 4).206
3.2. Impedimetric characterization of sensor207
The immobilization of A22 aptamers on the electrodes pro-208
voked an increase in the impedance due to increased charge209
transfer resistance at the electrode/liquid interface.210
The binding of the viruses to aptamers caused significant in-211
crease in the impedance already at very low concentrations.212
Washing the samples with PBS gave no significant change213
in the impedance signal, hence demonstrating that virus was214
bound to the aptamer.215
Control experiments, where high concentrations of virus216
were reacted with a mismatching aptamer gave no changes217
in the impedance signal compared to the baseline (data not218
shown).219
Figure 1 shows the electrochemical impedance spectroscopy220
(EIS) spectra of the impedimetric sensor presented in Nyquist221
plots from a typical experiment. The four traces refer to con-222
trol measurement in PBS and influenza A virus (H1N1) in223
PBS at increasing concentrations; 10 pfu/mL, 102 pfu/mL and224
105 pfu/mL, respectively. At low frequencies the impedance is225
dominated by mass transport of ions near the electrode surface,226
and thus considered to be the most sensitive range to investi-227
gate the binding event of a virus to an immobilized aptamer.228
Providing for the longer measurement time at low frequencies229
and signal-to-noise ratio, we found the optimal frequency for230
data analysis at 251 mHz, and this frequency was employed for231
all analyses.232
Control measurements in PBS reflects the impedance of233
the conductive polymer microelectrode array with immobilized234
aptamers without virus. Viruses were captured by the ap-235
tamer probes when influenza A virus (H1N1) was introduced236
into the system, this was reflected by a gradual increase in237
the impedance for increasing concentrations of virus. In the238
Nyquist plot this is visualized by a shift to the right towards239
higher resistance.240
The lowest concentration of virus tested in the experimen-241
tal setup was 10 pfu/ml, which corresponds to introducing 1 -242
2 pfu in the microfluidic system (volume ≤ 200 µL). A shift243
towards higher resistance was achieved at this dilution, indicat-244
ing that the sensor has a high specificity and sensitivity. The245
change in resistance is more evident for the highest concentra-246
tion of influenza A virus (H1N1) (10 pfu/mL), where numerous247
intact virus particles were captured by the immobilized aptamer248
probes (Figure 4).249
The dynamic range of the sensor was evaluated by testing di-250
lutions of influenza A virus (H1N1) in PBS (10 -106 pfu/mL).251
Figure 2 shows a typical impedance response displayed as the252
relative change in absolute impedance at frequency 251 mHz253
for increasing concentrations of virus. For every dilution of254
virus, the impedance was measured for 20 minutes, allowing255
the system to stabilize from the physical manipulation. Be-256
tween every dilution the sample was washed with PBS to re-257
move the unbound virus particles. When the system had stabi-258
lized, impedance data were collected (circa 20 values) and the259
mean was calculated and plotted. Error bars show the standard260
error of the mean.261
The sensor demonstrated a broad dynamic range - from262
10 pfu/mL to 106 pfu/mL. It begins to saturate at the highest263
concentrations of virus. The volume of the microfluidic chan-264
nel (including inlet and outlet) in the microsystem is less than265
200 µL, hence the sensor has very high sensitivity and can po-266
tentially detect 1 − 2 pfu, i.e. one or two intact influenza A virus267
(H1N1) particles in PBS.268
The broad dynamic range can be a useful feature in some269
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Figure 1: EIS spectra of the impedimetric sensor presented in Nyquist plots. (a) The full recoded range, and (b) zoom in lower frequency regime (2 Hz – 316 mHz).
The black (line), red (square), green (circle) and blue traces (triangle) refer to (i) control measurement in PBS, (ii) influenza A virus (H1N1) at a concentration of
10 pfu/mL, (iii) influenza A virus (H1N1) at a concentration of 102 pfu/mL, and (iv) influenza A virus (H1N1) at a concentration of 105 pfu/mL, respectively.
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Figure 2: A typical impedance response at frequency 251 mHz for increasing
concentrations of influenza A virus. The error bars display the standard error
of the mean.
applications, but in clinical settings a simple yes/no answer is270
sufficient to diagnose an influenza virus infection.271
To test the usability of the sensor in a realistic environment,272
saliva was diluted in PBS and spiked with influenza A virus273
(H1N1) at a concentration of 103 pfu/mL. Figure 3 shows the274
impedimetric detection of influenza A virus (H1N1) in saliva,275
with the absolute impedance displayed over time. A distinct in-276
crease in the measured impedance was observed immediately277
after injection of the sample. The control experiment remained278
unchanged, considering the slightly skewed baseline. The in-279
jection of sample at t = 7 minutes naturally caused a big dis-280
turbance in the system, hence the observed outliers. With the281
detection performance shown here, this sensor is a viable alter-282
native to conventional diagnostic methods and rapid influenza283
POC tests.284
Saliva is secreted by the salivary glands, and is easy obtained285
by untrained personnel, for example by a parent at home. Even286
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Figure 3: Electrochemical detection of influenza A virus at a concentration
of 103 pfu/mL in saliva (circle, red trace) and control measurement in saliva
(triangle, black trace). The system was stabilized with sterilized saliva and
samples were injected at t = 7 minutes.
so, employing saliva specimens to test for respiratory viruses287
such as influenza A virus is uncommon, because nasal secre-288
tions provide high concentrations of infected cells which is de-289
sirable for antigen detection (Robinson et al., 2008).290
The profile of virus shedding for influenza A virus peaks on291
illness days 1 or 2 and then declines steadily, whereas the viral292
load varies from subtype to subtype (Suess et al., 2012; Cowling293
et al., 2010; Lau et al., 2010). For a number to relate to, patients294
with 2009 pandemic influenza A (H1N1) virus had a mean ini-295
tial viral load in respiratory specimens of 108 copies/mL (To296
et al., 2010), which peaked soon after onset of clinical symp-297
toms - in accordance with the profile of virus shedding - and298
then decreased gradually to a range of 105 copies/mL around299
day 5 (To et al., 2010).300
Using this sensor, we could detect virus at a concentration301
of 103 pfu/mL in saliva diluted 1:10 in PBS, which is a rather302
4
low estimate bearing in mind the microvolume of the system303
and the typical viral loads in clinical specimens (more than304
100-fold higher). Controls, where a saliva specimen without305
influenza A virus (H1N1) was reacted with aptamer A22 gave306
no change in the absolute impedance signal compared to the307
baseline of saliva (Figure 3). Since saliva is composed of a vari-308
ety of substances including, electrolytes, enzymes, antibacterial309
compounds and at times viruses, this result comply with previ-310
ous studies demonstrating the high specificity of the aptamer311
A22. The result further comply with our finding, that influenza312
A virus (H1N1) failed to react with a mismatching aptamer.313
The impedimetric sensor detects very low concentrations314
of virus within minutes and it does not require the pres-315
ence of infected cells, consequently saliva specimens would316
be appropriate for analysis despite its lower concentration of317
viruses (Robinson et al., 2008). Moreover, there is evidence318
that influenza A virus (H5N1) - predicted by experts to be the319
next influenza pandemic - have higher concentrations of virus320
in the throat than the nasopharynx (Kandun et al., 2006).321
In literature, several impedimetric sensors for rapid detec-322
tion of influenza virus have been described, however, many323
are based on mono- or polyclonal antibodies, metal electrodes,324
need a label and require from 50 minutes to 2 hours to detect325
virus (Lum et al., 2012; Labib et al., 2012; Cheng et al., 2012;326
Wang et al., 2009). To the best of our knowledge, a device for327
sensing intact virus particles at clinically relevant concentra-328
tions in less than 15 minutes has not been reported before.329
The biosensor has high sensitivity and selectivity for the330
tested target, which make it a promising platform for fast and331
reliable diagnostics of intact viruses. In a similar experimental332
setup, we have with success tested antibiotics in milk (Dapra`333
et al., 2013), and combined with our newest results on influenza334
A virus (H1N1) we can conclude that larger targets will have a335
stronger effect on the impedance because it causes a greater dis-336
ruption of the electrochemical environment near the electrode.337
Consequently, this sensor potentially could be used to diagnose338
any virus if a probe with high affinity for the target molecule is339
available.340
3.3. Imaging Influenza Virus341
Atomic Force Microscopy imaging have been conducted to342
prove the binding of viruses to the surface of the conductive343
polymer microelectrodes. We have shown that influenza A344
viruses with a size approx. 100 nm were successfully immo-345
bilised on the functionalized electectrodes. Figure 4 shows346
samples with and without immobilized aptamers reacted with347
infleunza A virus (H1N1). Small spherical objects were scat-348
tered on the electrode surface on the sample which was func-349
tionalized with the A22 aptamer, while there were no particles350
on the electrodes and on the substrate, where no aptamer probes351
were immobilized. The small, irregular indentations visible on352
both samples in the high resolution images could originate from353
the glutaraldehyde treatment used to fix the bound viruses and354
in the PEDOT-OH:TsO film .355
4. Conclusion356
In summary, we have developed a new POC platform virus357
diagnostics. The disposable all polymer microsystem is highly358
sensitive, highly specific, highly stable, and has a very compet-359
itive response time of less than 15 minutes. The sensor could360
directly detect clinically relevant concentrations of intact in-361
fluenza A virus (H1N1) in saliva, and it displayed a broad dy-362
namic range. We have used influenza A virus (H1N1) in saliva363
specimens as an example to demonstrate the usability of the364
biosensor, and this could be an alternative to current diagnostic365
techniques.366
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3.2 Concluding Remarks
Electrochemical sensors play a significant role in the transition towards point of care
diagnostic devices. The electrical systems are extremely useful for delivering the diag-
nostic information in a fast, simple, and low cost fashion in connection with compact
analyzers.
The disposable all polymer microsystem presented here is highly sensitive, highly specific,
highly stable, and has a very competitive response time of less than 15minutes. The sensor
could directly detect clinically relevant concentrations of intact influenza A virus (H1N1)
in saliva, and it displayed a broad dynamic range. Saliva specimens spiked with influenza
virus were used as an example to demonstrate the usability of the biosensor, and this could
be an alternative to current diagnostic techniques.
There is room for improvements of the biosensor. The electrode material is very sensitive to
many environmental factors, such as temperature and pH. Introducing a third electrode or
measuring on two channels in parallel would allow for differential measurements where only
the signal change caused by the biological recognition event would be registered. For mass
production, standardization of electrode processing techniques would be required, since the
micropatterning of electrodes by agarose stamping is currently a manual procedure.
This is a modular biosensor platform based on electrochemical impedimetric sensing. The
microdevice can easily be modified by changing the biological receptors, offering a broad
range of possible applications. To keep the costs and the environmental footprint low,
the entire biosensor was designed in plastic; featuring a microfluidic channel and an elec-
trode system fabricated from conductive polymers. Aptamers were used as recognition
elements providing a more stable alternative to antibodies for easier handling and a longer
shelf life. Moreover, aptamers have a much wider range of possible target molecules than
antibodies.
The biosensor platform has successfully been adapted to different tasks and tested against
three very different analytes: DNA hybridization (Johannes Dapra and Dorota Kwasny;
manuscript in preparation), antibiotics [51] and influenza A virus. Throughout the ex-
periments the sensors showed high sensitivity and were able to detect very low analyte
concentrations in both buffered solutions, milk and saliva samples.
In summary, a novel biosensing platform was developed. Three prototypes of specialized
sensors were tested and they performed very well under laboratory conditions. Together
with some modifications and a suitable manufacturing solution this system has the poten-
tial for several marketable applications in the health care sector among others.

Chapter 4
Nanowire Based Biosensor
Nanowires still belong to the experimental world of laboratories, but they are predicted
a great future in medicine and diagnostics. Early experiments have shown that nanowires
are integrable as highly sensitive sensors in microdevices, and have the potential to push
forward a change in the practise of medicine towards point of care testing.
The field of silicon nanowires has been studied for a decade now, and a major remaining
challenge is processing costs. Recently, a new fabrication procedure was developed at DTU
Nanotech, enabling fast and cost effective production of conductive polymer nanowires [30],
allowing for effective utilization of nanowire microdevices as biosensors.
Our group just started working with conductive polymer nanowire microdevices as biosen-
sors, and we are still at a learning stage.
This chapter presents our preliminary results. Section 4.1 gives a brief introduction to
the new and easy fabrication procedure of conductive polymer nanowire devices. Pre-
liminary studies with cells are presented in Section 4.2, and the work is summarized in
Section 4.3.
4.1 Conductive Polymer Nanowires
Nanowires hold great promise for application in point of care devices for medicine and
diagnostics, with potential for miniaturization and integration. It has now been more than
ten years since the original paper on silicon nanowires was published, manifesting the
potential of this new type of biosensor [32]. Silicon nanowire biosensors have been studied
for detection of biological molecules as highly sensitive, label free and electrical tools.
The advantageous diameter of nanowires - comparable to the size of biological species -
makes them ideal for biosensing applications [52]. However, the main shortcoming of silicon
nanowire devices are expensive and time consuming fabrication procedures, obstructing
the development of disposable medical point of care systems.
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Costs are lowered with the realization of nanowires in conductive polymer materials such
as polyanaline [53,54] or PEDOT [34–36]. Nanowire devices have been demonstrated in ap-
plications, ranging from chemical gas and liquid sensor [55,56] to temperature sensors [57]
and biosensors [33,58,59].
Processing time of nanowires is significantly reduced by the use of a self assembled pep-
tide nanotube litography [30, 60]. The self organizing peptide nanotube structures were
employed as a masking material for rapid, mild and low cost production of PEDOT-
OH:TsO nanowires [30]. The new processing method was developed in the NaBIS group
at DTU Nanotech.
The fabrication procedure was optimized to comply with studies of living cells and virus.
In brief, the conductive polymer PEDOT-OH doped with tosylate was spun onto a wafer
containing gold connection patches. Self organizing peptide nanotubes were then spin
casted onto the surface of the wafer, and nanowires were patterned by a reactive ion etching
procedure. The spinning forced the polymer nanotubes to align radially on the surface of
the substrate, and ensured that conductive polymer nanowires were formed between gold
contact patches. Finally, nanotubes were dissolved in water, and a SU-8 passivation layer
was spun onto the surface. The entire fabrication procedure could be completed in half
a day. Nanowire devices were designed and fabricated by Karsten Brandt Andersen and
Nikolaj Ormstrup Christiansen, and the procedure is sketched in Figure 4.1.
A cell chamber was fabricated in polycarbonate, and the low cost microdevice was exploited
for real time and label free electrochemical detection of living cells.
4.2 Cellular Studies
Sensing at a single cell level provides new opportunities in medical diagnostics. It is an
emerging field, and has been recognized as a key technology for the elucidation of cellular
functions, which are not accessible from bulk measurements on the population level. Single
cell techniques let researchers track and catalogue the heterogeneity of cells to address
fundamental questions regarding the biochemistry and functionality of individual cells,
and what makes them different.
Many traditional cellular assays are based on the characterization of populations of cells,
rather than single cell dynamics. Conclusions drawn from these studies may be mislead-
ing on a single cell level. Hence, single cell analysis has become a requirement in modern
medicine. Current techniques include capillary electrophoresis and flow cytometry. These
methods require the addition of fluorescent conjugates which could alter the original cel-
lular functions [61], and the experimental procedure makes real time monitoring a chal-
lenge.
The presented microdevice is based on label free electrochemical detection, allowing for
non invasive studies of single cell dynamics within a population of cells to preserve the
natural cellular environment.
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Electrochemical impedance spectroscopy is a sensitive technique for label free, non inva-
sive studies of cells. By detecting minute changes in the cell membrane capacitance, it can
provide relevant information about the functional status of a single living cell without dis-
rupting the microenvironment. In general, impedance spectroscopy has gained popularity
for its simplicity, sensitivity and opportunity for downscaling into portable point of care
devices.
Impedance spectroscopy was used to measure the initial attachment and spreading of
a single cell on a conductive polymer nanowire substrate. Control measurements were
conducted in cell medium. Healthy fibroblast cells were seeded in the microdevice, and
electrochemical impedance spectroscopy experimentation (no redox couple added) was
carried out in a tightly controlled environment at 37 ◦C, 5% CO2. Impedance spectra
were recorded every 33 s in the frequency range from 1Hz to 10KHz with an amplitude
of 20mV in a two electrode setup. The optimal frequency for the time dependent analysis
was found at 1Hz, and determined by the highest response to changes on the cells.
Figure 4.1: Fabrication of conductive polymer nanowires. (a) Gold electrodes were defined
by a lift off procedure, (b) Conductive polymer was spin coated on the substrate, (c) self
organizing peptide nanotubes were spin casted on the substrate (spinning ensured desired
alignment), (d) conductive polymer nanowires were patterned by ion etching, and peptide
nanotubes were dissolved in water. Finally, a passivation layer was applied by spin coating
and patterned by standard photolitography. The entire process could be completed in half
a day. Adapted from [30].
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Figure 4.2: Electrochemical detection of single cell adhesion on conductive polymer
(PEDOT-OH:TsO) nanowire. (a) and (b) display the relative impedance change at a fre-
quency of 1Hz from two independent measurements.
Single cell adhesion on a conductive polymer nanowire was monitored in real time, and Fig-
ure 4.2 shows the typical impedance changes at a frequency of 1Hz. The initial attachment
and spreading of a single cell was reflected by a gradual increase in the impedance until
a plateau was reached after approximately 2.5 hours (Figure 4.2(a)). We have previously
shown that the adhesion of a cell population follows a similar curve [13]. In Figure 4.2(b),
the impedance increased rapidly, peaked within two hours, and then decreased slightly
before reaching a plateau. The minor difference in the impedance change could result
from the position of the cell on the wire. Other factors come into play, such as nanowire
dimensions, cell morphology and cell motility. The microscopy image in Figure 4.3 dis-
play a nanowire spanning between gold contact patches. Atomic force microscopy images
at higher resolution illustrate that a cell was immobilized on the wire (Figures 4.3(b)–
(d)).
4.3 Concluding Remarks
The current fabrication procedure does not allow any control of the size and distribution
of the nanowires. Moreover, the current microdevice design does not allow us to combine
electrical measurements with video time lapse microscopy, complicating experimentation.
This will be dealt with in the next prototype, where we plan to fabricate conductive
polymer nanowires on a thin transparent sheet of Topas®.
Imaging of nanowires with human cells verified that alignment of a cell on the nanowire
varied from experiment to experiment, therefore real time video time lapse microscopy is
essential for proper data treatment.
The next step is to develop an improved prototype with nanowires fabricated on a trans-
parent substrate, and study cell adhesion on nanowires by video time lapse microscopy
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Figure 4.3: Cell on conductive polymer (PEDOT-OH:TsO) nanowire. (a) Microscopy im-
age of nanowire spanning between gold contact patches, (b) atomic force microscopy topo-
graphy image of cell on nanowire, (c) and (d) atomic force microscopy topography images
of cell on nanowire at high magnification.
and electrochemical impedance spectroscopy. Subsequently, the early effects of virus or
drug induced cell death of single cells in real time will be studied.
The cellular response to toxins or chemicals is usually measured as an average over a
population of cells (refer to Chapter 6). By employing conductive polymer nanowires,
the immediate response to a drug or virus could be detectable at single cell level in real
time.
In another experimental setup the use of aptamer functionalized nanowires for direct
detection of virus gave promising results, but further experiments are required. Electrical
detection of single viruses in real time on conductive polymer nanowires have a possibility
for large scale integration and potential for simultaneous detection of a large number of
distinct viral threats at single virus level.

Chapter 5
Cell Based Biosensor
Review
5.1 Introduction
Microfluidic systems for cell based biosensing provide advantageous opportunities in medi-
cine and diagnostics [4]. Adapting living cells as recognition elements in a biosensor instead
of material that has been extracted from living cells yields an attractive sensing platform,
allowing for direct screening of biological active analytes. Cells are very sensitive to minor
changes in the cellular microenvironment, hence cell based biosensors are sensitive and
accurate tools for rapid detection of physiological effects.
Cell based biosensors are very versatile and have a wide range of applications, for example
in drug discovery, personalized medicine and medical diagnostics.
Costs and risks involved in the development of pharmaceuticals continue to rise and strin-
gent regulatory requirements are put in place, creating a need for technologies that can
accelerate the process of drug discovery. Cell based biosensors provide a cost efficient
platform for fast and accurate screening of known and unknown drug candidates.
The microenvironment in microfluidic devices is highly controllable; consequently con-
ditions mimicking the natural cellular environment are achievable. This is an essential
feature, making cell based biosensors ideal for the upcoming market in personalized medi-
cine.
This chapter is concerned with cell based biosensors relevant to medical diagnostics. In
this review article, microfluidic device considerations are covered, and three promising
electrical transducing technologies facilitating real time analysis of cells are introduced.
Short response time is important for application in point of care diagnostics, and live
information concerning the state of cells allow for precise control in cell based biosensors.
It will be a challenge to bring the sensors out of the laboratory, some potential applications
are mentioned in the article.
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Abstract: Cell-based biosensors provide new horizons for medical diagnostics by adopting
complex recognition elements such as mammalian cells in microfluidic devices that are
simple, cost efficient and disposable. This combination renders possible a new range of
applications in the fields of diagnostics and personalized medicine. The review looks at the
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1. Introduction
Emerging pathogenic viruses or resistant bacteria in animals more frequently make the headlines than
a decade ago. In a global community the outbreak of disease is a source of worry for the population, and
the increased interest has indeed emphasized the need for new effective diagnostic screening solutions
for point of care (POC) testing.
POC is an emerging field within medical diagnostics and disease monitoring, and eventually disease
control. Integration of nanomaterials, microfluidics, automatic samplers, and transduction devices on a
single chip provides many advantages for POC devices such as biosensors. Making use of specially
designed microsystems [1], patients can be monitored continuously at bed side or at the general
practitioner, and save precious time in commuting between home, doctor and hospital. The technological
advancements in cell-based biosensors have accelerated the R&D in POC devices.
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Conventional detection methods in medical diagnostics, such as polymerase chain reactions (PCR)
and enzyme linked immunosorbent assays (ELISA), or whole animal testing are time consuming, labour
intensive and expensive [2,3]. Accordingly, it is important to develop effective screening tools to detect,
control and confine the spread of biohazards.
Cell-based biosensors—with living cells as the recognition element—are characterized by high
sensitivity, selectivity and rapid response. They are very versatile and thus applicable in different fields
such as food safety, environmental monitoring, drug screening and medical diagnostics. Cell-based
biosensors are able to measure functional information and in this way help us to understand the cellular
mechanisms behind particular diseases to improve the development of targeted treatment.
Cell-based biosensors can be constructed to detect the response of a single cell, a cell layer, or a
network of cells. The mammalian cells are the most common recognition elements in the microsystems,
allowing physiologically relevant studies of a cellular response to one or more compounds, or effects.
Several transducer methods are used for the recognition events including optical absorption and
fluorescence, acoustic detection, surface plasmon resonance, electrical and electrochemical methods.
Electrical signal detection can readily be integrated in biosensors and thus is an attractive alternative to
other detection methods.
This review will focus on the recent developments of cell-based biosensing in microfluidic systems
with electrical and electrochemical transduction that are relevant to medical diagnostics without aspiring
to completeness. Readers interested in more general aspects of cell-based biosensors are directed to
several other excellent review articles [4–8].
2. Device Considerations
For the new generation of POC diagnostics, sensors have to be producible at reasonable cost and fulfill
high standards to outmatch the conventional techniques in medical diagnostics. Cell-based sensors are—
by nature—very specific and sensitive giving a rapid response. Careful design considerations regarding
the microfluidic channel network, electrode system, and selection of materials can further improve the
microdevice significantly while maintaining them at low cost.
2.1. Microfluidic Systems
The microscale channels in a microfluidic device enable the use of extremely small volumes of
expensive chemicals and low concentration of analyte. Since most of the bio- and chemical reactions are
determined by diffusion of the molecules to the adequate places, the short distances in a microsystem
permit the rapid detection by reducing the diffusion times. Both the mass and heat transport are
faster in a microsystem, allowing a quasi-equilibrium state for the biochemical processes. A variety of
microstructures can be used for optimization of transport processes, e.g., vortices, pillars, or herringbone.
A defined microfluidic environment is convenient for cellular studies because the physiological and
electrical responses of single cells can be detected. All these desired properties of microfluidic devices
are favourable in many biological and medical applications [9].
The majority of microfluidic cell culture systems are designed for adherent cells [10,11], as these are
the dominant cell types used in biological studies. Besides, the handling and perfusion of fresh media
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for culturing of adherent cell types is much easier. Recently, a cell culturing microfluidic reactor for
culturing both adherent and non-adherent cells was presented. It allowed precise control of pH, oxygen,
nutrition and temperature, and sustained the biochemical microenvironment of the cells, while supplying
nutrients to the cells by diffusion controlled processes [12]. By producing miniature electrodes on the
surface of the microchannels, electrical or electrochemical signals from the cells could be recorded in
real time.
2.2. Materials for Fabrication
The choice of materials for fabrication of microfluidic devices is a very important factor. Since the
1990s, several studies have originated on interfacing materials with living cells, with the goal of detecting
biocomponents or biological processes. The considerations include biocompatibility of the materials,
transparency for microscopy, and wettability for aqueous liquid handling [13,14]. Initially, silicon and
glass were the most attractive materials for microdevices due to well developed fabrication technologies
for semiconductors and micro-electro-mechanical-systems (MEMS).
More recently, polymers have gained popularity, because both the polymer material and the
polymer manufacturing techniques (injection molding and hot embossing, replica molding, casting) are
inexpensive [15]. Several polymers have physical, mechanical, and chemical properties that meet the
demands for biosensing, for example polydimethylsiloxane (PDMS), polymethylmethacrylate (PMMA),
polyethylene diacrylate (PEG-DA), polycarbonate, cyclic olefin copolymers (COC).
PDMS is typically employed for prototyping because of its many excellent properties (including
gas permeability, transparency, flexibility, and biocompatibility). The surface of native PDMS is
hydrophobic, but can be made hydrophilic by surface modification with plasma, UV/ozone, or corona
discharge. The oxidized surface remains hydrophilic if it stays in contact with water, and can be modified
further by treatment with functionalized silanes [16]. PDMS seals reversibly to a variety of materials
such as glass, hard plastic, silicon, flat metal, photoresist, and native PDMS.
Mass production of polymeric devices is commonly done by the injection moulding technique using
COC [17,18], and only few polymers are suitable for production of microscale structures with injection
molding. COC is a thermoplastic polymer with desirable physical and chemical properties, such as high
optical transmittance, low water absorption, biocompatibility and high chemical stability in aqueous
media, alkaline, acidic, and polar solvents. Hence, this material is particularly attractive for disposable,
cost effective, reliable microfluidic devices with lab-on-a-chip applications.
The novel material Graphene has emerged as an attractive candidate for the biointerface [19,20].
Graphene is a two dimensional sheet of hybridized carbon atoms arranged in a honeycomb lattice, and
it exhibits several superior and atypical properties owing to a unique combination of its crystallographic
and electronic structure. Due to these properties, it can be a sensitive platform for interfacing with
biological cells to detect intra- and extracellular phenomena, including cellular excretion and potential
modulation of the cell membrane. Although these applications are lacking of maturity, cell interfaced
graphene devices can open avenues for diagnostics and single cell analysis in the future [20].
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2.3. Sensing Unit
A major cost factor in electrical and electrochemical sensors is the sensing unit. Electrodes are
typically made in a noble metal, involving extensive production steps and cleanroom facilities.
Afterwards, surface treatments with a bio- or biocompatible material are required to attain
biocompatibility with living cells. For cell-based applications the surface of the metal electrodes can
be covered with an extracellular matrix protein to improve cell adherence.
Conductive polymer electrodes present an alternative to noble metals. In addition to low material
cost, electrode fabrication is inexpensive, and the electrodes are easily functionalized [21]. The use of
conductive polymers as supporting materials in microfluidic systems is well established. However, the
electronic sensing units in most microdevices are fabricated from metallic conductors such as platinum
or gold.
Biocompatibility and functionalization of electrodes is of great importance in cell-based biosensor
applications, where cells are immobilized directly on the electrode surface. The conductive polymer
poly(3,4-ethylenedioxythiophene) (PEDOT) has high environmental stability, biocompatibility,
transparency to visible light and ease of processing [21]. This polymer has shown high potential and
superior quality [22,23], and it has been employed in several biosensor microdevices [24,25].
Figure 1. Electrochemical current response of microelectrodes for the presence of a single
cell. The larger electrodes were incapable of resolving a single cell, whereas the use of small
electrodes produced a clear change in the electrochemical impedance spectroscopy signal.
In general, the electrode design has major impact on the electrical readout, and the sensing unit should
be designed and optimized in accordance with the application. The demands for studies of the dynamics
of a cell culture on a conductive polymer interdigitated electrode array [25] are different than the
demands for single cell investigations on an Au microelectrode array [26], or electrical characterization
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of single cells on polysilicon wires [27,28]. Figure 1 illustrates the electrochemical current response of
microelectrodes for the presence of a single cell, hence emphasizing the effect of electrode design on the
electrical signal.
2.4. Microfluidic Design
Microfluidic technology is creating powerful tools for cell biologists to control the complete cellular
microenvironment, leading to new questions and new discoveries [29].
For cellular analysis it is often necessary to culture the cells. The standard methods (e.g., culture
flasks) do not represent a natural environment. Microfluidic culturing systems for adherent and
non-adherent cells allow for precise control of the environment and diffusion based feeding, where
important chemicals are not flushed away as it can be the case in conventional cell culture flasks [12].
At micrometer scale, we have a detailed understanding of fluid behaviour, which confers unique
potential to microfluidic gradient generating methods. Laminar flow based micro gradient generation
devices are used for diffusive mixing of two or more parallel laminar streams of different composition
to generate molecular gradients. Gradients generated in these types of devices will maintain their shape
in time and space at constant flow rate. The analysis of cell migration in different regions of both
chemotactic and haptotactic gradients [30] is relevant for the improved understanding of among others
wound healing, cell invasion, and tumour progression.
An intelligent microfluidic cell culture system allows precise control of cell adhesion by temperature
changes [31]. The shear stress dependent cell detachment process was investigated in five individual
microchannels, where surfaces were coated with the well known temperature responsive polymer
Poly(N-isopropylacrylamide) (PIPAAm). To estimate the interaction between cells and the PIPAAm
layer, the cells were exposed to a flow in the microchannels, and the shear stress generated by this flow
was used as a key factor for cell detachment. The proposed device could be used to assess the possible
interaction between the cells and the PIPAAm layer with a potential application in tissue engineering.
3. Principles of Transduction
The feasibility of sensors that can convert the cellular signals from living cells to electrical signals in
real time depends especially on cost, usability, sensitivity, and specificity. Real time sensing provides
live information regarding the state of the cells, allowing for precise control. This is of great importance
in POC applications where rapid response is crucial, or in long term cytotoxicity studies. When cell
viability has a relevance (rather than the cell count) real time sensing is advantageous. The three
principles of transduction described here enable real time sensing.
3.1. Electrochemical Methods
Electrochemical sensors produce an electrical signal in response to an electrochemical reaction
between an analyte and the surface. Direct electrochemical signal detection is preferable, because the
use of a simple set of electrodes greatly reduces the complexity, size and costs—factors that are typically
associated with other methods, such as optical detection.
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Buchinger et al. have evaluated the chrono-amperometric detection method in a reporter gene assay
based on the bacterial response in comparison with standardized methods [32]. It was shown that the
chrono-amperometric detection—under optimized electrochemical conditions—is sufficiently sensitive
with a limit of detection that is comparable to the respective ISO-standard.
Among cell-based assays, impedimetric sensors have attracted attention for the high sensitivity,
reliability and simplicity [33–38]. Electrochemical impedance spectroscopy combined with
microelectrode arrays provide a platform for label free detection of the cellular response to different
drugs or pathogens [39,40]. The interaction between a cell monolayer and the electrode surface can
be monitored in real time by applying a small amplitude alternate-current (AC) electric field. Cells
are essentially non-conducting at low frequencies and the cell membrane offers a significant barrier to
current flow, so that the impedance of the system is an indication of the cell volume or size [41]. Average
alterations in the three dimensional shape of cells is then computed by integrating over a monolayer
of hundreds or thousands of cells. The measured impedance reflects changes in the attachment and
morphology of cells, and reaches its maximum when the electrode is completely covered [25,42,43].
3.2. Field Effect Devices
Field effect devices use an electric field to control the conductivity of a semiconducting material.
The integration of living cells together with silicon field effect devices challenges a new generation of
biosensors and bioelectronic devices. Among the variety of proposed concepts, the integration of living
cells together with a silicon chip consisting of an array of (bio)chemical and/or electrophysiological
transducers, based on a field-effect electrolyte/insulator/semiconductor system is one of the most
attractive approaches. The cell/transistor hybrid is obtained by direct coupling of a single cell or cell
system to the gate insulator of a field effect transistor (FET) (Figure 2). This system is very sensitive to
any kind of electrical interaction at or nearby the gate insulator/electrolyte interface.
Figure 2. Cell/transistor hybrid. The open gate area of the FET is completely covered
by one cell as indicated in the schematics (RE: reference electrode; VG: gate voltage;
VDS: drain-source voltage; ID: drain current).
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The state of a single cell or cell system can be monitored by means of various methods, such
as (i) utilisation of the metabolism of cells like growth, toxicity, extracellular pH, redox potential,
concentration of ions, etc., (ii) utilisation of specific features of electrogenic cells, e.g., neuronal cells,
or muscle cells by measuring the extracellular potentials [44,45].
3.3. Light Addressable Potentiometric Sensors
Light addressable potentiometric sensors (LAPS) use light to activate carriers in a semiconducting
material. LAPS (Figure 3) are popular in chemical and biological applications, primarily because of
high spatial resolution and because the measuring point can be selected by a scanning light beam [46].
Figure 3. Schematic set up of a LAPS device with living cells and light sources
(RE: reference electrode; Vbias: bias voltage; Iph: generated photocurrent).
Electrochemical interactions between the transducer surface and the analyte generate surface
potentials. They are then added to the applied DC bias voltage. To detect the gate insulator surface
potential, the LAPS is illuminated with a modulated light source using laser beam or light emitting
diodes (LED) in portable devices. The light source induces an AC photo current, which is measured as
the sensor signal.
The light pointer in a LAPS device can be addressed at individual cells in culture, allowing for
single cell analysis on chip. Although many cells are cultured on a chip surface, only the cell(s) in
the illuminated area is interrogated.
4. Applications
Cell-based sensors are applicable in many areas of medical diagnostics, and have a large potential in
the emphasized fields.
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4.1. Pathogens and Toxins
Electrochemical impedance spectroscopy measured on cells cultured on a microelectrode array is very
sensitive to small changes in the cell membrane capacitance and resistance (Figure 4). These parameters
are good indicators for the well being of cells at a given cell morphology. The real time detection of cell
impedance gives an efficient and rapid technique for non-invasive monitoring of the response of human
cells in culture to the challenge of a virus infection [25,47,48], or a drug [49,50].
Figure 4. Cell-based biosensor. (a) All polymer microdevice with two functional channels
fabricated in TOPAS (uncolored) and PEDOT:TsO (blue). (b) Healthy cells cultured on
PEDOT:TsO microelectrodes in the biosensor.
Cardiac cell-based biosensors have been used to study toxicity induced by a drug or heavy metal
ions [51–53]. The toxic effects of ions lead to clear alterations in the action potential and were detectable
within fifteen minutes [52].
4.2. Single Cell Analysis
Single cell analysis is of importance in certain aspects of medicine. Regeneration of neural tissue is
very complex and requires multiple signals for axonal regrowth and functional recovery of damaged
nerve tissue [54]. Microsystems allow cultures to be seeded at very high density in two or three
dimensions to achieve cell-cell contact and generate an environment more anatomically similar to living
tissue. Scaffolds of electrically conducting fibers immobilized with neural growth factor on PPy present
multiple stimuli simultaneously and are attractive for neural cells, serving as a guidance and supporting
neurite formation and outgrowth [55]. Understanding the complex signaling of neurites is a key in
the process of understanding neurite migration and differentiation. A quantitative measure of cellular
transmitter release by neuronal cells was measured by electrochemical techniques. The cells were
trapped in a closed microchip close to a band of microelectrodes [56].
4.3. Drug Discovery
Cell-based biosensors with intact living cells as the sensor allow for screening of virtually any drug.
Synchronization of the cell cycle by serum starvation is a common technique to enhance the cellular
response [57].
Wound healing is complex process and it can be examined and accelerated in a biosensor [58].
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Migration assays and invasion assays are well suited for drug screening by rapidly and quantitatively
measuring cell movement and the ability to traverse physical barriers. The microfluidic technology
presents an appealing strategy to control fluid flow necessary to generate gradients on a scale suitable
for cellular migration studies. New gradient generating methods to study chemotactic [59–61] or
haptotactic [62] cell migration are considered more advantageous than conventional methods such as the
transwell assay [63]. A novel microfluidic migration device imitates the physiological conditions of cell
transmigration (Figure 5) [64]. The principles of a shear flow chamber were combined with the transwell
assay in a microfluidic system that closely resembles the natural environment of migrating immune
cells. Microchannels were physically separated by a porous membrane, and the cells actively migrated
towards a pore in response to a chemotactic gradient, similarly to extravasation from blood vessels to
underlying tissue. In this work, the transmigrating cells were mapped using fluorescent imaging, but an
electrode array could be implemented to count migrating immune cells by electrochemical impedance
spectroscopy.
Figure 5. Microfluidic device for studies of chemotactic cell migration. The chip was
fabricated in PMMA and contained separate channels for cells and chemoattractants. This
type of assay has application in drug screening [64].
4.4. Cancer
Early-stage diagnosis of cancer is the critical factor for treatment and patient survival. Primary tumors
can often be removed with advanced therapies and drugs. Unfortunately, many cancers are diagnosed
after cancer cells have escaped from the primary tumor site, circulated with the blood stream to form
secondary tumor sites throughout the body. Currently, invasion and metastases of tumors are the main
reasons for patient mortality. The invasion properties of different cell lines were studied in a cell-based
biosensor by electrical impedance spectroscopy [65]. New techniques are required for diagnosis and
monitoring. Sensors with ultra-low detection limits can be targeted towards emerging cancer biomarkers
(indicators of tumor growth), cancer cells in circulating blood (indicators of metastasis) and to determine
drug effectiveness at various target sites. Precise counting of breast cancer cells was achieved on a gold
microelectrode array via label free electrochemical impedance spectroscopy based detection at a single
cell level [66,67].
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5. Conclusion and Outlook
Elegant multidisciplinary research collaborations have provided new horizons for cell-based sensing
in medical diagnostics. Lately, we have seen a wide variety of microsystem based sensors with many
different clinical applications such as high throughput drug screening. Cell-based biosensors further
have application in tissue engineering for regeneration of highly organized tissues facilitated by the
patterning technologies. Some of the new cell-based biosensing systems will meet the requirements of
high specificity and sensitivity, low cost, simplicity, and rapid readout—they raise the bar for sensors
and qualify for point of care systems. There are limitations to cell-based biosensors such as shelf life,
and it will be a challenge for researchers to bring the sensors out of the laboratory to be managed by
untrained personnel. However, cell-based biosensors have a unique ability to simulate the physiological
in vivo response, and will certainly continue to revolutionize sensing of pathogens and toxins in the
near future.
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5.2 Concluding Remarks
Biosensing platforms continue to gain ground i medicine and diagnostics, and the ongoing
advances in cell biology and microtechnologies has contributed to the development of
highly sophisticated cell based biosensors. These rapid in vitro screening platforms have
a broad range of applications in industry and research, and having moral and ethics in
mind - cellular platforms can to a certain extent replace animal based experiments.
Chapter 6
Cell Based Biosensor
Detection of Virus
6.1 Introduction
Personalized medicine and diagnostics are rapidly growing fields of research and general
interest. Cell based biosensors employ living cells as sensing elements, and are impor-
tant tools for individual patient care, providing information about cellular mechanisms
for improved understanding of disease mechanisms, early diagnosis and targeted treat-
ment.
By nature, cells are very selective and sensitive to small changes in the cell environment.
Culturing cells on microelectrodes in microfluidic systems offer a high degree of control
of the local cell environment, and precise analysis of cell development in response to
stimulation by electrical detection methods. Compared to traditional cell culture dishes,
microfluidic channels offer refined fluid control, low sample consumption and reduced
interference, which is an advantage in many biological and medical applications [62].
The reference standards for laboratory confirmation of many virus infections are reverse
transcription-polymerase chain reaction (RT-PCR) or viral culture. High sensitivity and
specificity of RT-PCR makes it attractive, however the method lacks indication of the via-
bility of virus or on-going viral replication, and moreover, it is expensive, time consuming
and require well equipped laboratories and trained personnel. RT-PCR is also associated
with multiple potential technical errors, including failed extractions and problems with
PCR inhibition [63]. Viral culture is time consuming, and depending on the type of virus
it may require a week or more to obtain the results.
In this paper, we present a biosensor for fast and sensitive detection of viral infections in cell
culture. An all polymer microfluidic system was fabricated in Topas® by injection molding,
and conductive polymer (PEDOT:TsO) microelectrodes were patterned using standard
photolitographic processing techniques. Human cells were immobilized on the conductive
polymer microelectrodes, and the effects of infection with human cytomegalovirus were
studied by electrochemical impedance spectroscopy and video time lapse microscopy.
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The  demand  in  the  ﬁeld  of  medical  diagnostics  for  simple,  cost  efﬁcient  and  disposable  devices  is  growing.
Here,  we  present  a label  free,  all-polymer  electrochemical  biosensor  for  detection  of  acute  viral  disease.
The dynamics  of a  viral  infection  in  human  cell  culture  was  investigated  in a micro  ﬂuidic  system  on
conductive  polymer  PEDOT:TsO  microelectrodes  by  electrochemical  impedance  spectroscopy  and  video
time  lapse  microscopy.
Employing  this  sensitive,  real  time  electrochemical  technique,  we could  measure  the  immediate  cell
response  to cytomegalovirus,  and  detect  an  infection  within  3 h, which  is several  hours  before  the  cyto-
pathic effect  is  apparent  with  conventional  imaging  techniques.  Atomic  force  microscopy  and scanning
ion  conductance  microscopy  imaging  consolidate  the electrochemical  measurements  by  demonstrating
early  virus  induced  changes  in  cell  morphology  of  apparent  programmed  cell  death.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
In a global community, the outbreak of infectious diseases con-
tributes to the fear of severe pandemics, and is a source of worry
for the population. In recent years, emerging viruses have been a
focus of attention (e.g. Dengue virus, West Nile virus, Inﬂuenza A
virus) and has thus emphasized the need for new effective tools in
medical diagnostics. Conventional diagnostic methods for detec-
tion of acute viral disease, such as polymerase chain reactions (PCR)
and enzyme linked immunosorbent assays (ELISA) are time con-
suming, labour intensive and expensive (Cheng et al., 2009; Lazcka
et al., 2007). Accordingly, it is important to develop effective point-
of-care tools to detect, control and conﬁne the spread of virulent
diseases in the near future.
Recently, there has been great advancements in the biosensor
technology, and in particular impedimetric sensors have attracted
attention for the high sensitivity, reliability and simplicity (Chen
et al., 2010; Primiceri et al., 2009; Diouani et al., 2008; Hnaien et al.,
2008; Daniels and Pourmand, 2007; Mathebula et al., 2009).
∗ Corresponding author.
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(N. Rozlosnik).
Among cell based assays, electrochemical impedance spec-
troscopy combined with microelectrode arrays provides a platform
for label free detection of the cellular response to different drugs
or pathogens (Arias et al., 2010; Ona and Shibata, 2010). The inter-
action between a cell monolayer and the electrode surface can be
monitored in real time by applying a small amplitude alternate-
current (AC) electric ﬁeld. Cells are essentially non conducting at
low frequencies and the cell membrane offers a signiﬁcant barrier
to current ﬂow, so that the amplitude of the AC ﬁeld is an indication
of the cell volume or size (Cheung et al., 2005). Average alterations
in the three dimensional shape of cells is then computed by inte-
grating over a monolayer of hundreds or thousands of cells. The
measured impedance reﬂects changes in the attachment and mor-
phology of cells, and reaches its maximum when the electrode is
completely covered (Giaever and Keese, 1986; Keese and Giaever,
1994).
Electrochemical impedance spectroscopy (EIS) measured on
cells cultured on a microelectrode array is very sensitive to small
changes in the cell membrane capacitance and resistance. These
parameters are good indicators for the well being of cells at a given
cell morphology. The real time detection of cell impedance gives
an efﬁcient and rapid technique for non invasive monitoring of
the response of human cells in culture to the challenge of a virus
infection (McCoy and Wang, 2005; Campbell et al., 2007).
0956-5663/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
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In general, viral infections can induce degenerative morpho-
logical changes in cell cultures; cell detachment from substrate,
release of cell–cell adhesions, cell round up and eventually cell
death. Beside the morphological effects, these changes in the cells
produce a decline in the resistance and an increase in the capaci-
tance in the impedance signal (McCoy and Wang, 2005; Campbell
et al., 2007).
Polymer based microﬂuidic systems meet the requirements of
disposable devices, low sample consumption, cost efﬁciency, reli-
ability, and fast response time, which make the systems ideal
for point-of-care analysis. By employing conductive polymers
as electrode materials, the additional advantageous proper-
ties of inexpensive electrode fabrication and easy electrode
functionalization can be achieved (Rozlosnik, 2009). This fea-
ture is of great importance in biosensor applications, where
particles or cells are immobilized directly on the electrode sur-
face.
In the present study, an all polymer microsystem with a
PEDOT:TsO microelectrode array was developed and exploited for
real time and label free electrochemical detection of the effect of
human cytomegalovirus (CMV) on cells. In this work, we show that
the novel biosensor technology demonstrates a fast and sensitive
response to the small changes in the cell morphology induced by
infectious agents, and thus presents a strongly competitive alter-
native to the current detection techniques opening a wide range of
applications.
2. Experimental procedures
2.1. All polymer microdevice
The all polymer microﬂuidic device was composed of four layers
(Fig. 1). Top and bottom pieces were fabricated from the cyclic oleﬁn
copolymer TOPAS 5013L (TOPAS Advanced Polymers, Germany;
Tg  134 ◦C) by injection moulding (Victory 80/45 Tech, Engel,
Germany). The top part contained access ports in standard luer lock
size for ﬂuid inlets, outlets and electrical connections. The second
layer – microchannels and reservoirs – were deﬁned in an 80 m
thick, pressure sensitive adhesive (PSA, ARcare 90106, Adhesive
Research, USA) by laser ablation (Duo Lase CO2 laser, Synrad Inc.,
USA). The electrodes in the third layer were made from a conductive
polymer, poly(3,4-ethylenedioxythiophene) doped with tosylate
(PEDOT:TsO). The EDOT monomer (Baytron M)  and Fe(III)-tosylate
(40% in butanol, Baytron C) were purchased from Bayer AG (Lev-
erkusen, Germany). Conductive polymer coatings were fabricated
using in situ polymerization of EDOT with Fe(III) tosylate as oxida-
tion agent. This yields a highly conducting polymer (PEDOT:TsO)
coating with a sheet resistance of ∼100 /sq (Hansen et al., 2010;
Daugaard et al., 2008).
Electrodes and electrical connection patches were patterned in
the PEDOT:TsO layer using standard photo lithographic process-
ing techniques in the Danchip Cleanroom (Technical University of
Denmark, Denmark).
The ﬁnal chip was assembled by thermal assisted bonding at 55 ◦
C with 55 kg force applied for 5 min  in an in house build, LabView
(National Instruments, USA) controlled press. Prior to the bonding
step, top and bottom pieces with the patterned PEDOT:TsO elec-
trode layer were cleaned in air plasma (50 W,  30 s; OEM-6AM-1B,
ENI Power Systems, USA)
2.2. Cell culture
Human foreskin ﬁbroblast (HFF; ATCC Cat. No. SCRC-1041; LOT:
58592555) cells were cultured in monolayers in a humidiﬁed incu-
bator at 37 ◦C, 5% CO2 in Dulbecco’s modiﬁed Eagle’s medium
Fig. 1. Microdevice production: (a) Microdevice with two  functional channels
fabricated in TOPAS (uncolored) and PEDOT:TsO (blue), (b) microchannel with inter-
digitated microelectrode array, and (c) schematic representation of fabrication steps.
(For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of the article.)
(DMEM, Invitrogen, Carlsbad, California, USA) supplemented with
10% Fetal Bovine Serum (FBS, F7524, Sigma, St. Louis, Missouri,
USA), Penicillin 10,000 U/ml, and Streptomycin 10,000 g/ml (PS,
DE17-602E, Lonza, Basel, Switzerland). The cells were subcultured
by trypsination for maintenance every third day, or at ∼80–90%
conﬂuence.
2.3. Preparation of virus stock
Human CMV, (Towne strain; kindly provided by Thomas
Kledal, Inagen ApS, Denmark) was  employed as infectious agent
against HFF cells. Human CMV  is a ubiquitous ˇ-herpesvirus
that causes widespread, persistent infection in the human host.
Virus was propagated and titered in HFFs, and infection of cells
was  performed in DMEM supplemented with 10% Nu Serum
(355500, BD Biosciences), and 1% PS. Virus with a multiplic-
ity of infection (MOI) of 0.01 was  adsorbed for 2 h at 37 ◦C,
overlaid with medium, and incubated for the required num-
ber of hours post infection (hpi). The cell medium was  changed
at 100% cytopathic effect, and virus was  harvested two days
later.
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Fig. 2. EIS spectra of the impedimetric sensor presented in Nyquist plots. (a) The full recoded range, and (b) zoom in higher frequency regime. The green, red and black traces
refer  to (i) immediately before cells were seeded in the microchip, (ii) 14 h after cells seeding, and (iii) cells infected with human CMV, respectively. (For interpretation of
the  references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
2.4. Virus puriﬁcation
Medium from infected cell cultures was collected and cen-
trifuged at 1260 × g for 10 min  at 4 ◦C, and the virus was sedimented
by centrifugation at 24, 336 × g for 1 h at 4 ◦C. The pelleted virus was
resuspended in DMEM supplemented with 1% PS, layered over 20%
Fig. 3. Electrochemical detection of cell spreading and proliferation (a) and the
effect of human CMV infection (b) on HFF cells cultured on PEDOT:TsO microelec-
trodes in the biosensor. The cell index – deﬁned in Eq. (1) – was measured at a
frequency of 2 Hz. The green, red and blue traces refer to three independent mea-
surements on cells infected with human CMV  at a MOI  of 3 at t = 0. The grey trace
refers to the measurement adding cell medium instead of virus containing solution
at t = 0. (For interpretation of the references to color in this ﬁgure legend, the reader
is  referred to the web version of the article.)
sorbitol in Tris-buffered saline, and puriﬁed by centrifugation at
50, 228 × g over night at 4 ◦C. The pelleted virus was resuspended
in DMEM supplemented with 1% PS, aliquoted, and stored at −80 ◦C.
Virus titer was determined by plaque titration assay using methyl
cellulose and crystal violet staining.
2.5. EIS on cell culture
Healthy HFFs were seeded directly on a conductive polymer
electrode surface in the micro channel of the chip (Fig. 1), and
allowed to attach and spread on the substrate and acclimatize
over night. EIS was used to monitor the electrical properties of
the cell monolayer before and after the introduction of pathogen.
The microchip was placed in a temperature controlled incubation
chamber, and EIS experimentation (no redox couple added) was
carried out in a tightly controlled environment at 37 ◦C.
Impedance spectra were recorded every 33 s in the frequency
range from 0.2 Hz to 100 KHz with an amplitude of 10 mV  in a two-
electrode setup.
The optimal frequency for the time dependent analysis – deter-
mined by the highest response to changes on the cells – was  found
at 2 Hz (Fig. 2). This frequency was used for all analyses. We  deﬁned
a cell index
CI = (Zcell(t)Zcell(0) − 1) · 100 (1)
where Zcell(0) and Zcell(t) are the measured impedance on the chip
at the beginning of the measurement and after a time t, respectively.
The cytopathic effect on cells was  monitored in an inverted
phase contrast microscope (Nikon Eclipse Ti-S/L100, Japan) with
auto focusing controlled by dedicated software. A digital camera
(VisiCam 3000, VWR) recorded time lapse movies with intervals of
15 min  for 20 h. In the presented results, cells were inoculated with
human CMV  at an MOI  of 3.
2.6. Imaging virus infected cells
HFFs were grown in petri dishes and infected with human CMV
at a MOI  of 5 in 1 ml.  At given time points post infection (.5, 1, 1.5, 2,
and 3 h), cells were washed twice with preheated infection medium
to remove residual virus, ﬁxed in 2% glutaraldehyde in Phosphate
Buffered Saline (PBS; (1×),  Lonza) for 60 min  at room temperature,
and washed with PBS for 15 min  at 4 ◦C. Samples for investigations
by scanning ion conductance microscopy (SICM) were stored in
PBS at 4 ◦C. Fixed cell samples for atomic force microscopy (AFM)
studies were dehydrated by increasing concentrations of ethanol
(30–99%) for 3 min  on a shaker at room temperature and freeze
dried over night (Tojima et al., 1998; Kirk et al., 2009).
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Fig. 4. AFM topography images of ﬁxed HFF cells at different time points post infection with human CMV. Cell morphology was affected by virus, and arrows indicate some
adverse cellular protrusions. (a) Control cell. (b) 1 hpi the cell has contracted and formed narrow ﬁlamentous projections. (c) 2 hpi the ﬁlamentous projections are beginning
to  spread-out. (d) 3 hpi the cell body has somewhat recovered its size and shape though adverse spread-out protrusions remain present. Enlargment of the nucleus and
nuclear  DNA fragmentation can be observed, which are the hallmarks of apoptosis.
2.7. AFM imaging
AFM images were recorded with a DME-SPM (Dualscope II,
Denmark) in tapping mode using standard non contact high
frequency cantilevers (TAP300Al, Budget Sensors) with a force con-
stant of 40 N/m. AFM examinations were carried out in air at room
temperature.
2.8. SICM imaging
SICM images were recorded with an XE-Bio system (Park Sys-
tems, Korea) in adaptive Approach-Retract-Scan (ARS) mode with
borosilicate capillary glass pipettes (inner diameter of 80 nm). SICM
examinations were carried out in PBS at room temperature.
3. Results and discussion
An all polymer microsystem was fabricated by injection mould-
ing and standard photo lithographic processing techniques (Fig. 1),
and exploited for label free, real time, electrochemical detection of
infectious agents in human cell culture.
3.1. Microchip design considerations
The low cost microsystem was fabricated in TOPAS with inter-
digitated electrodes in the conductive polymer PEDOT:TsO. PEDOT
was  selected for its high environmental stability, biocompatibil-
ity, transparency to visible light and ease of processing (Rozlosnik,
2009). Before producing the all polymer microdevice, ﬁnite ele-
ment method simulations (COMSOL Multiphysics 3.5) were made
for optimizing the geometry of the conductive polymer electrodes
and the microchannel shape (results are not shown). Microchannels
offer reﬁned ﬂuid control, low sample consumption, and reduced
interference, which is favorable in many biological and medical
applications (Stott et al., 2010).
Although PEDOT:TsO is a redox system, this impedimetric sen-
sor is based on the low frequency response (i.e. non faradaic
region) with no additional electron-transfer mediators. Previous
studies on impedimetric immunosensors have shown that this
scheme is more amenable to biosensor applications (Berggren et al.,
2001; Rickert et al., 1996), because the long term presence of a
redox-couple reduces the activity of the enzymes (Rickert et al.,
1996).
The biocompatibility of the all polymer biosensor chip was
evaluated by culturing HFF cells in the chip for a week (see
Fig. S1 in Supplemental Data available online). The cells adhered
and proliferated normally on TOPAS and PEDOT:TsO, and no signif-
icant change in the morphology of cells could be observed during
this period. On the other hand, the morphological changes on the
virus infected cell culture could easily be observed on the samples
in a time frame of 12–24 hpi (see Fig. S2 in Supplemental Data avail-
able online).
390 K. Kiilerich-Pedersen et al. / Biosensors and Bioelectronics 28 (2011) 386– 392
Fig. 5. SICM topography images of ﬁxed HFF cells at different time points post infection with human CMV. Cell morphology was affected by virus, and arrows indicate some
adverse cellular protrusions.(a) Control cell. (b) 30 min  post infection the cell has contracted and formed narrow ﬁlamentous projections. (c) 3 hpi the cell body has recovered
its  size and shape though adverse spread-out protrusions remain present.
3.2. Electrochemical detection of virus
HFF cells were cultured in a monolayer on the conductive poly-
mer  substrate over night to allow the cells to get acclimatized
before virus inoculation.
Fig. 2 shows the EIS spectra of the impedimetric sensor pre-
sented in Nyquist plots. The three traces refer to (i) immediately
before cells were seeded in the microchip, (ii) 14 h after cells seed-
ing, and (iii) cells infected with human CMV, respectively. The
higher frequency regime (>3 kHz, semicircle) corresponds to the
charge transfer at the electrode-solution interface (faradaic cur-
rent) and is determined by the charge transfer resistance and the
double layer capacitance, while the impedance at low frequencies
is dominated by diffusion (i.e. mass transport of ions). Considering
that the ion diffusion is expected to be much faster in the liquid
solution than in a solid material, this part of the spectrum is antic-
ipated to be the most sensitive for the changes on the electrode
surface. At very low frequencies the measurement of one single
point takes relatively long time, and the sensitivity is not improved
signiﬁcantly, therefore we have selected the highest reasonable
frequency (i.e. 2 Hz).
The initial attachment and spreading of cells on the electrode
surface was reﬂected by a gradual increase in the impedance until
a plateau was reached (Fig. 3a), because the healthy cells act as an
insulating layer on the electrode surface (Giaever and Keese, 1986)
by blocking the diffusion of the ions to the electrodes. A second rise
in the cell index is observed after 4 h, reﬂecting the proliferation of
cells (Fig. 3a).
When the cells were infected with human CMV  at a MOI  of 3
at t = 0, the infection was detectable within 2 hpi – several hours
before the cytopathic effect appeared. The immediate cell response
to virus was mirrored by a drastic ﬂuctuation in the impedance at
low frequencies, and thus in the cell index (Fig. 3b). At 2 Hz, the
absolute impedance peaked at around 1.5 hpi to reach a local maxi-
mum and then gradually decreased to a local minimum in the hours
that followed, reﬂecting the inter- and intra-remodeling events
caused by the virus. No sign of proliferation was  observed on virus
infected cells.
In control measurements, cell medium was added at t = 0
instead of virus containing medium. The absolute impedance
decreased slightly to reach a plateau within 30 min  after the
physical manipulation. Over a period of 10 h, the absolute
impedance increased in response to proliferation (Fig. 3b, grey
trace).
In all cases, we observed a linear increase in the impedance sig-
nal (a drift) at all frequencies in the system. This drift arose most
probably from swelling of the pressure sensitive adhesive, in which
the microchannels were deﬁned, and it was  subtracted (as a base
line) from each impedance curve.
To investigate the effect of the infection in microscopy, high
resolution images of healthy and virus infected HFF cells were
captured 1, 3 and 8 hpi with human CMV  at high dose (MOI 10).
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The early cellular changes were not observable in microscope (see
Fig. S3 in Supplemental Data available online).
Video time lapse microscopy studies of cell cultures showed that
the cytopathic effect of the virus manifested itself approximately
8–10 hpi depending on the MOI  (see Virus-infected-cells.mp4 video
ﬁle in Supplemental Data available online).
The application of EIS as a sensing tool for quantifying virus
or drug induced cell death in cell cultures has previously been
reported, e.g. cells infected with inﬂuenza A virus (McCoy and
Wang, 2005), infectious pancreatic necrosis virus (Campbell et al.,
2007) or infectious hematopoeitic necrosis virus (Campbell et al.,
2007). In those studies, the terminal stages of cell death (lysis and
detachment from substrate) were detected by EIS, rather than the
early morphological features related to a virus infection. These
changes are only detectable after many hours or even days, and
they can also be imaged by phase contrast microcopy. In certain
cases a clear spike in resistance was reported at the time of virus
inoculation (McCoy and Wang, 2005; Campbell et al., 2007), how-
ever, we presume that this was attributed to physical manipulation
and was not caused by the virus. In our measurements, the short
term response to virus was directly monitored by the impedance
changes, which allowed us to recognise the virus infection in the
very early stage (Kukura et al., 2009; Seisenberger et al., 2001).
Cell survival and appearance of the cytopathic effect depend on
the dilution of virus. Our preliminary impedimetric studies on cells
infected with different dilutions of human CMV  indicated that the
change in the absolute impedance at 2 Hz was highly dependent
on the amount of virus (data not shown). Our data implied that
the initial peak shifted in time in response to virus dose. Further
investigations are required to determine the exact concentration
dependence.
3.3. Early morphological signs of apoptosis
Complementary imaging investigations were performed to
understand the biology that gave rise to the drastic changes in
impedance associated with virus infection.
AFM of ﬁxed infected cells permit structural investigations of
the cell surface at high resolution. Topography scans 1, 2, and 3 hpi
(Fig. 4) demonstrate that the cytoskeleton organization is aber-
rantly rearranged within few hours post infection. During the initial
phase of high dose infection (MOI of 5), the cells contract and ﬁl-
amentous projections occur, presumably in response to a calcium
inﬂux (Albrecht et al., 1983; Sharon-Friling et al., 2006). Around
3 hpi, the cell body recovers its size and shape, though adverse pro-
trusions remain present. These distinct morphological features – in
particular the changes in cell surface area – clarify the impedimetric
changes caused by the virus infection.
The topography scans further indicate adverse nuclear morphol-
ogy, which is a hallmark of apoptosis (Ghibelli et al., 1995; Gadaleta
et al., 2002; Jurak et al., 2008). Some viruses have been reported to
induce programmed cell death in the absence of viral replication,
for instance triggered by the interaction with a cellular membrane
receptor or entry and uncoating of the virion (Jan and Grifﬁn, 1999).
AFM images were captured in air to obtain a high resolution,
even though the drying process of the samples could inﬂuence
the 3D cellular structure. Therefore, SICM images were captured
in liquid to preserve the cellular structure.
SICM is an emerging non contact scanning tool based on ion
currents through a micro pipette, providing true topography of
soft samples (Boecker et al., 2007; Korchev et al., 1997). The tech-
nique has several advantages over AFM; an essential feature is that
no imaging force is exerted on the sample. SICM images (Fig. 5)
exhibit detailed information from the cell surface structure, and
display ﬁne structures, which are smeared out or not visible in the
AFM image. Further, cell–cell interactions are more evident by SICM
imaging than AFM imaging. Protrusions and cellular extensions are
challenging to sight in the AFM image, however, the cytoskeleton is
very detailed, an attribute to the direct mechanical contact during
scanning (Rheinlaender et al., 2011). Therefore, the scans obtained
by AFM and SICM imaging accentuate different morphological char-
acteristics and thus complement each other.
4. Conclusion
In summary, we  have developed a disposable polymer microsys-
tem with PEDOT:TsO microelectrodes for rapid, label free, and real
time electrochemical detection of infectious agents in human cell
culture. We  have demonstrated that an infection of HFF cells with
human CMV  causes drastic changes in the cell index within the ﬁrst
3 hpi. Thus, the infection is detectable much faster than by con-
ventional assays. To comprehend the cellular changes at this early
stage in the infectious cycle, virus infected cells were examined by
AFM and SICM imaging. Our investigations indicated the rearrange-
ment of cytoskeleton organization and the early signs of apoptotic
nuclei within 3 h post virus infection explaining the results of
the impedance measurements. Compared to conventional inspec-
tion techniques, the use of inexpensive electrochemical biosensors
(which is also suitable for mass production) can thus signiﬁcantly
reduce the time frame of virus diagnostics.
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1. Supplementary Information
1.1. Cell Viability on Chip
The biocompatibility of the all polymer biosensor chip was evaluated
by culturing HFF cells for a week. Cells were seeded on the conductive
polymer microelectrode array in a microfluidic channel at low density. The
cells adhered and proliferated normally on TOPAS and PEDOT:TsO, and
no significant change in the morphology of cells could be observed during
this period (Figure S1). On the other hand, the morphological changes on
the virus infected cell culture could be observed on the samples in a time
frame of 12 − 14 hpi (Figure S2).
1.2. Video Time Lapse Microscopy Studies
HFF cells were seeded in Nunc 24-well plates and infected with human
CMV (MOI 10) at ∼ 70 % confluence. PlasDIC images (20x, Zeiss) were
captured every 15 minutes for 15 hours, and the experiment was performed
in a humidified incubator at 37 ◦C, 5 % CO2. The studies showed that the
cytopathic effect of human CMV manifested itself around 8 hpi depending
on the MOI (Figure S3).
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Figure S1: Cell viability on chip. HFF cells adhere, spread and proliferate on
the conductive polymer electrode substrate in the microchip. On the sixth
day, cells were exposed to flow at a high flow rate to decrease the number of
cells.
2
Figure S2: HFF cells cultured on PEDOT:TsO microelectrodes in the biosen-
sor. (a) Healthy cells, and (b) cells infected with human CMV (MOI of 3,
24 hpi).
Figure S3: PlasDIC (20x) images of healthy and virus infected human fore-
skin fibroblast cells. Images were captured 1 , 3 and 8 hpi with human CMV
at high dose (MOI 10). Video time lapse microscopy of cell cultures show
that the cytopathic effect of the virus manifested itself around 8 hpi.
3
1.3. Virus Infection on Electrodes
A monolayer of HFF cells were infected with human CMV at an MOI of 3
at t = 0. Phase contrast images (10x, Zeiss) were captured every 20 minutes
for 15 hours to monitor the morphological changed induced by the virus at
a specific position in the micro channel. The cytopathic effect was apparent
after around 8 hpi at this virus dose.
Enclosed movie (Virus-infected-cells.mpg4): HFF cells infected with hu-
man CMV at an MOI of 3.
4
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6.2 Concluding Remarks
Electrochemical sensors have received major attention in biosensor development, because
these low cost devices comprise a simple, sensitive and accurate platform for personalized
medicine and diagnostics.
Electrochemical methods are very sensitive to small changes in the membrane capaci-
tance of cells. By employing impedance spectroscopy, we could measure the immediate
cell response to virus, and detect an infection with a herpes virus within three hours post
infection, which is several hours before the cytopathic effect is apparent with conventional
imaging techniques. In previous studies of drug- or virus induced cell death, the terminal
stages of cell death rather than the early morphological signs related to the drug or virus
were detected. Atomic force microscopy and scanning ion conductance microscopy imag-
ing consolidated the electrochemical measurements by demonstrating early virus induced
changes in cell morphology of apparent programmed cell death.
In its present design, the biosensor represents a competitive alternative to current labora-
tory based virus detection techniques in terms of sensitivity, response time, and cost.
With some modifications of the design to improve user friendliness and with optimized
fabrication processes, we believe, that the novel all polymer biosensor platform has appli-
cation in virus diagnostics or personalized medicine for drug testing to achieve targeted
treatment.

Chapter 7
Cell Migration in
Microfluidic Device
7.1 Introduction
Advanced polymer devices for improved cell handling, culturing and analyses are becoming
increasingly important in modern medical research, diagnostics and therapy. Although, im-
pressive research breakthroughs have been achieved with conventional cell culture dishes,
the system far from resemble in vivo conditions, thus translation of data for clinical use
is difficult and has to be done with delicacy.
Migration of cells - essential for all living organisms - is a key in the development of the
immune system, influenced by many different factors in the blood and the surroundings.
Some cells are said to be intrinsically motile, whereas other cells need at least a global
stimulation with a chemoattractant to initiate movement [64]. A continuous redistribution
of cells to different anatomic sites throughout the body is central to immune surveillance
and host defence [65], and an in depth comprehension of the immune cell trafficking pat-
terns is imperative to understanding the role of specific cells in disease processes and to
devising rational therapeutic strategies.
Recruitment of leukocytes from the circulation into sites of injury or inflammation requires
the coordinated action of cellular adhesion proteins and chemotactic factors, mediating
sequential leukocytes rolling, triggering, adhesion, and extravasation to peripheral tissue
(Figure 7.1) [66, 67]. The complexity of the cell environment makes it difficult to model
in vitro, and the conventional cell migration assays are far from mimicking the natural
conditions.
Microfluidics is an appealing strategy to control fluid flow necessary to generate gradi-
ents in a scale suitable for cellular studies. Novel gradient generating methods to study
chemotactic [69–71] or haptotactic [72, 73] cell migration are considered more advanta-
geous than the conventional methods [71, 74], such as the Boyden Chamber [75] or shear
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flow chamber [76].
In this paper, we present a new assay for real time studies of cell transmigration. We
developed a microfluidic device incorporating the principles of a traditional Boyden cham-
ber and shear flow chamber. The system imitate the natural environment of immune cells
by maintaining a stable and constant concentration gradient of chemoattractant, while
introducing shear flow action on migrating cells.
Figure 7.1: Schematic model of the classical pathway in the adhesion cascade. Leukocyte
migration from the circulation into the peripheral tissue is a stepwise process. The first step
involves transient, weak selectin-mediated binding. Chemokines that have been presented
by glycosaminoglycans activate integrins on leukocytes, triggering firm adhesion between
the leukocytes and endothelial cells. Finally, leukocytes migrate through the endothelial
layer in response to a chemokine gradient. Modified from [68].
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Abstract The development of new drug therapies relies
on studies of cell transmigration in in vitro systems.
Migration has traditionally been studied using two
methods, the Boyden chamber and a shear flow cham-
ber assay. Though, commonly applied in cell transmi-
gration studies, they are far from imitating a natural
migration process. Here we describe a novel in vitro
cell transmigration microfluidic assay, which mimicks
physiological shear flow conditions in blood vessels.
The device was designed to incorporate the principles
of both the Boyden chamber and the shear flow cham-
ber assay, i.e. migration through the membrane under
flow conditions. The 3D environment of migrating cells
is imitated by injecting cell adhesion proteins to coat
the membrane in the device. We tested the developed
device with Jurkat cells migration towards medium
supplemented with serum, and with chemokine induced
lymphocytes migration. The applied continuous flow
of cell suspension and chemoattractant ensures that
the concentration gradient is maintained in time and
space. The cell adhesion proteins used to enhance cell
migration in the device were fibronectin and VCAM-1.
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We successfully observed a multistep transmigration
process by means of the developed microfluidic migra-
tion assay. The presented device is inexpensive, easy
to fabricate and disposable, having a potential to be
applied in basic research as well as in the drug devel-
opment process.
Keywords Cell migration · Microfluidic migration
assay · Shear stress · Lymphocytes
1 Introduction
Cell migration plays an important role in a variety
of physiological and pathological processes, such as
angiogenesis, cancer metastasis, embryonic develop-
ment, wound healing and inflammation. It is a complex
process, essential for all living organisms, and it has
been under investigation for many years (Finger et al.
1996; Lawrence et al. 1997; Guan 2005; Nie et al. 2007).
Novel therapies and drug development rely on a proper
understanding of the migration process.
Recruitment of leukocytes is central to immune
surveillance and host defense (Nowak and Handford
2004). Trafficking from the circulation into sites of in-
jury and inflammation requires the coordinated action
of cellular adhesion proteins and chemotactic factors,
mediating sequential leukocyte rolling, triggering and
adhesion (Frow et al. 2004; Goldsby et al. 2006). Leuko-
cytes circulating in postcapillary venules are pressed
to vessel walls due to collisions with red blood cells,
and extravasation into sites of inflammation is me-
diated by sequential adhesive interactions between
surface receptors on leukocytes and their endothe-
lial counterligands (Goldsby et al. 2006; Hamann and
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Engelhardt 2005). The activation of leukocytes by lig-
ands on endothelial cells occurs within seconds in vivo
under blood flow (Butcher and Picker 1996). It is im-
portant to rapidly stop rolling cells because they have
to react at the specific sites of chemokine stimulation
(Campbell et al. 1998).
During extravasation from the vessels, receptors on
the leukocyte surface detect an extracellular signal due
to which the cell orients and starts to move directly
towards a gradient of chemoattractant (Kay et al. 2008).
Such guided movement was first described for the
soil amoeba Dictyostelium disoideum and since then it
became a model organism for eukaryotic chemotaxis
studies (Jin and Hereld 2006). Migrating leukocytes
undergo a series of transformations leading to redistrib-
ution of chemokine receptors, integrins and cytoskele-
tal proteins (Mackay 2001). The cell surface becomes
irregular with rapid protrusions and retraction of ruffles
due to actin polymerization changing the cell morphol-
ogy to a polarized form with actin concentrated at
the leading edge (Wilkinson 1996). A trailing end of
the cell is not an essential part but is particularly well
seen in lymphocytes (Baggiolini 1998; Rot et al. 2004;
Wilkinson 1996).
Significant efforts have been focused on immune
system cell migration studies in drug development to
determine factors influencing migration. These studies
identified numerous elements such as chemoattractants
and cell adhesion proteins mediating transmigration
of leukocytes in post capillary venules, but also the
importance of shear stress (Lawrence et al. 1997; Finger
et al. 1996; Toetsch et al. 2009). Development of new
drugs relies on in vitro model systems to test potent
drug candidates and determine their influence on cell
migration (Toetsch et al. 2009). Conventionally, migra-
tion was studied in an in vitro gradient generating assay
called a Boyden chamber. It consists of two wells, one
inserted into another separated by a porous membrane,
which is a static model to study cell transmigration
(Boyden 1962). The introduction of a shear flow cham-
ber assay solved the lack of shear flow acting on cells
in the transwell assay. It consists of endothelial cells
grown on a transparent surface and a system to perfuse
leukocytes under different shear flow values. Real time
microscopic observation is performed to monitor the
sequential adhesive interaction of leukocytes and cell
adhesion proteins expressed on endothelial cells. Con-
trary to nature, where a soft tissue underlies blood ves-
sels, cells are grown on a solid support, which does not
enable true transmigration (Hamann and Engelhardt
2005).
The complexity of the cell environment makes it
difficult to model in vitro (Breckenridge et al. 2010),
and the conventional cell migration assays are far
from mimicking natural conditions. In nature, leuko-
cytes present in vessels are exposed to a continu-
ous blood flow. Thus, a new in vitro migration assay
should imitate physiological conditions in the capil-
laries by mimicking transmigration from blood vessels
under flow conditions. The investigation of the entire
transmigration process in regards to cell movement
analysis is important in drug development. Novel anti-
inflammatory drugs are designed to act on different
groups of proteins to inhibit either the rolling or the ad-
hesion step (Proudfoot et al. 2000; Pitzalis et al. 1997).
The transwell system is an endpoint assay that allows
cell quantification after the migration event, with no
means to track the transmigration process itself. In
contrast, the shear flow chamber is used to observe
the sequential adhesive interactions between leuko-
cytes and cell adhesion proteins, but no real trans-
migration to underlying tissue is possible. Thus, the
investigation of the complete transmigration process
is impossible to achieve with existing assays. There is
therefore a need for a new system enabling real time
monitoring of cell migration under physiological flow
conditions.
Here we describe a novel cell migration assay based
on the principles of both Boyden chamber and flow
chamber assays. This device meets the requirements
for a novel cell transmigration assay maintaining a
constant concentration gradient, introducing shear flow
action on migrating cells, as well as imitating the natural
environment of cells. The microfluidic system enables
studies of cell migration in the context of interactions
between chemoattractants, cell adhesion proteins and
migrating cells under physiological shear flow condi-
tions. The device facilitates control of shear stress,
which is an important factor in regulating expression of
cell adhesion proteins that mediate the transmigration.
The continuous flow of chemoattractant ensures the
stable concentration gradient in time and space. An-
other unique feature of the demonstrated microfluidic
device is its ability to monitor sequential adhesive in-
teractions between leukocytes and proteins coated on
a membrane. The role of VLA4 integrin expressed on
leukocytes was tested by interactions with fibronectin
and VCAM-1 proteins on the membrane. To demon-
strate the applicability of the device to monitor steps
involved in cell migration in real time, we tested the
migration of Jurkat cells and lymphocytes purified from
blood towards fetal bovine serum and 50 ng/ml CCL2
chemokine respectively (Carr et al. 1994). The system
enables studies of all steps involved in the cell migration
process with potential application in basic research and
therapeutic drugs screening.
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2 Materials and methods
2.1 Device design
The microfluidic device was designed in AutoCad2000i.
The design is based on the principles of the Boyden
chamber and the shear flow chamber. It consists of
two narrow flow channels imitating blood vessels in
which shear stress is controlled by a syringe pump. The
channels are separated by a porous membrane as shown
in Fig. 1. It acts as a physical barrier, separating cells in
the upper channel from a chemoattractant solution in
the lower channel. The design allows for coating of the
membrane after thermal bonding of a complete device
to imitate the 3D environment of migrating cells.
2.2 Device fabrication
Two 500 μm wide, 100 μm deep and 2 cm long chan-
nels were milled by a high precision milling machine
(Folken Industries, Glendale, USA) in a 2-mm poly
(methylmethacrylate) (PMMA) sheet (Nordplast) and
cut out in the dimensions of a microscope glass slide
(75 × 25 mm). The channels contain separate inlets
and outlets for cell suspension and chemoattractant
solution. The interconnections were milled as described
by Sabourin et al. (2010) to fit a 3-mm silicone tubing.
After defining the channels, the device parts were
cleaned with MilliQ water, further washed with
ethanol, treated with UV (Dymax EC5000, Connecti-
cut) for 1 min and thermally bonded at 85◦C, at
a pressure of 5 kN for 15 min in a bonding press
(P/O/Weber, Remshalden, Germany). During bonding,
a 5 μm pore size polycarbonate (PC) membrane (Pieper
Filter GmbH, PC50BP02500) was sandwiched between
the two parts of the device separating them and ensur-
ing that the membrane covered the overlying channel
Fig. 1 The principle of migration through a PC membrane in
the microfluidic device. Cells flowing in the upper channel can
sense a chemoattractant diffusing through pores from the bottom
channel and migrate through the membrane
parts. The three elements of the device are shown in
Fig. 2 before and after the bonding process. Silicone
and Teflon tubing (VWR) were used to interconnect
the device with a syringe pump.
2.3 Cell culture and purification
Jurkat cells were cultured in RPMI media (Invitro-
gen, 61870) containing 10% Fetal Bovine Serum (FBS)
(Sigma Aldrich, F2442) and 1% Penicilin/Streptomycin
(Invitrogen, 15140) in a humidified incubator at 37◦C
in a 5% CO2 moist atmosphere. The cells were synchro-
nized for 12 h before the migration experiments by FBS
starvation.
Buffy coat was isolated from a blood sample ob-
tained from healthy donors (blood bank, Rigshos-
piltalet, Copenhagen, Denmark) by centrifugation
with Ficoll Paque PLUS (GE Healthcare, 17-1440-02)
following the manufacturers protocol. Lymphocytes
were resuspended in RPMI medium and used for
experiments.
Fig. 2 The schematic drawing of three elements of the device
during assembling (a) and after thermal bonding (b). 1 Cell
suspension channel, 2 Membrane, 3 Chemoattractant channel
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2.4 Device operation
The device was primed with liquid by flushing 10%
ethanol solution, followed by washing with MilliQ
water and 1× PBS (Invitrogen, AM9625). The cell sus-
pension channel and the membrane were coated by in-
jecting 10 μg/ml fibronectin (Sigma Aldrich, F0895) or
5 μg/ml VCAM-1 (PeproTech, 150-04) solutions to the
cell suspension channel for 1 h at 1.67 × 10−3 m/s flow
velocity. Both microfluidic channels were subsequently
blocked with 1% Bovine Serum Albumin (BSA)
(Sigma Aldrich, B4287) solution to prevent unspecific
binding. Medium supplemented with 10% FBS acted as
a chemoattractant for Jurkat cells while 50 ng/ml CCL2
(Biosource, PHC1014) solution induced migration of
lymphocytes. The cells were stained with DiO dye
(Invitrogen Molecular Probes, V22889) as described
by the manufacturer just before device testing. La-
beled cells at a concentration of 1 × 106 cell/ml in
serum free medium were pumped into one channel at
1.67 × 10−3 m/s flow velocity. At the same time the sec-
ond channel was filled with chemoattractant solution
at 1.67 × 10−3 m/s flow velocity. The chemoattractant-
induced migration was observed with a fluorescent
microscope equipped with a camera (Photometrics Cas-
cade II512, USA). Experiments were performed at a
room temperature with a disposable device. Glass sy-
ringes were used to ensure a stable flow.
2.5 Simulation of concentration gradient
The concentration gradient across the membrane
was simulated in the multiphysics modeling software
COMSOL 3.5. In the analysis, a 2D model of the
device was created with channel dimensions of 0.1 ×
20 mm separated by a porous membrane of thick-
ness 10 μm with a pore size of 5 μm, porosity 0.14
and 20 mm length. For the purpose of the simulation
the concentration of chemoattractant in the bottom
channel inlet was normalized to 1, while the upper
channel is free of chemoattractant at the beginning
of the analysis. Fluid dynamics calculations were per-
formed using the Navier-Stokes equation with a flow
velocity of 1.67 × 10−3 m/s, and a fluid viscosity of
1 × 10−3 Pa.s. To obtain a concentration profile, Fick’s
law of diffusion was applied. The diffusion coefficient
of CCL2 was calculated to be 1.76 × 10−10 m2/s taking
into account the effective radius of a protein and a
molecular weight of CCL2 8 kDa. Diffusion through
the membrane was simulated by setting the diffusion
coefficient in the membrane to 0.14 of the calculated
value for CCL2, to account for the membrane porosity.
Similarly, convection through the membrane was sim-
ulated considering Darcy law for convection in porous
media as described in Dimaki et al. (2008). The flow
problem was solved first in steady state and the solution
was used afterwards to calculate the time-dependent
diffusion. As a control, the same simulation was re-
peated by using a geometrical representation of the
membrane instead of the Darcy law.
2.6 Imaging and analysis
Videos were recorded on an inverted fluorescent
microscope (Nikon Eclipse TE2000, Japan) with a
EMCCD camera (Photometrics Cascade II512, USA).
The sequence of images was further processed with Im-
ageJ and analyzed manually from AVI files (7 frames
per second) to obtain coordinate trajectories of loco-
motive cells in time. The cell coordinates were used
to create a scatter plot of the cells’ trajectories with
changing velocity using Matlab.
3 Results and discussion
3.1 Microfluidic device
The complete device in a shape of a microscope slide
is shown in Fig. 3. The channels serving as the migra-
tion platform are well defined by micromilling. During
thermal bonding the two parts of the device were
connected and a PC membrane was incorporated to
separate the channels, which can be seen in Fig. 3 as
Fig. 3 The microfluidic device for cell transmigration studies
fabricated in PMMA. The chip contains separate channels for
cell suspension and chemoattractant flow. The middle part of the
device consists of channels separated by a PC membrane which
serves as a migration site
Biomed Microdevices (2011) 13:899–907 903
a circle in the middle part of the chip. The plus sign
visible in the corner of the device is an indication of a
cell suspension channel inlet for easier device handling.
The microscope slide format was chosen as standard
in biological analysis as well as for easy handling during
investigation of the cell migration. The placement of
interconnections on each side of the slide is crucial for
easy operation at a microscope stage. During device
fabrication a proper alignment of the membrane in the
central part of the device has to be assured, because
the membrane separates the overlapping parts of the
channels serving as migration point. Misalignment of
the membrane would result in mixing of cell suspension
and chemoattractant solution. The 2.5 cm membrane
diameter was selected to cover the 2 cm long overlap-
ping channels region. Furthermore, the membrane has
to be stretched to prevent folding in the channels which
could influence the microscopic investigation.
3.2 Gradient simulation
The time evolution of the chemokine concentration
gradient in the top channel is plotted in Fig. 4. In the
top part of Fig. 4 the channel outline is sketched with
a dashed line indicating the membrane position. The
concentration change with time and channel length was
plotted at 5 μm above the membrane. In Fig. 4(a)
the time dependent change in concentration within 25
seconds is plotted. Each line represents the time of the
simulation, at the beginning of the assay the concentra-
tion of chemokine in the top channel is equal to 0.1 of
input concentration. The concentration of chemokine
in the top channel increases with time and length of the
channel being the highest after 20 seconds of simula-
tion. After this time, the concentration of chemokine in
the end of the top channel reaches the highest value of
0.3 of input concentration, with no further change ob-
served, proving that the gradient across the membrane
is formed within few seconds of the experiment and re-
mains stable with time. In Fig. 4(b) the simulation using
a real geometrical representation of the membrane is
shown. The only differences noted are an oscillating
concentration profile with the largest concentrations
directly above the pores, as can be expected, and the
value of the highest concentration in the top channel
was 0.25 of the input concentration.
The device consists of two channels with continu-
ous flow applied during experiments. The chemokine
diffuses through the membrane from the beginning of
the experiments, but because of the flow in the top
channel it is moved to the end of the channel. Thus,
the simulated concentration in the top channel is the
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Fig. 4 The simulation of the concentration gradient formation in
the microfluidic device. The channels outline is sketched above
the graphs, with a dashed line as a membrane. The chemoat-
tractant concentration was measured at 5 μm above the mem-
brane. (a) The graph of concentration of chemoattractant in the
top channel changing with time and channel length. (b) The
oscillating concentration profile simulated with a geometrical
representation of the membrane
highest in the end of the channel. The observed cell
behavior during experiments confirms the correctness
of the simulation, as the cell migration was higher in
the end of the channel.
3.3 Migration in the device
The migration in the microfluidic device was recorded
with an inverted fluorescent microscope equipped with
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a CCD camera. The device was mounted on a mi-
croscope stage and the cell movement was recorded
looking through the device while focusing on the mem-
brane. The obtained data are movies of cells as they
interact with a membrane coated with adhesive sub-
strates under shear flow conditions (Q = 5 μl/min and
a shear stress of 1 dynes/cm2). A control experiment
was also prepared by observing Jurkat cell behavior
on an uncoated membrane in a prototype device with
a higher flowrate of Q = 10 μl/min and a shear stress
of 1 dynes/cm2. The movies visualize the moment of
cell transmigration through the membrane as the cell
is out of focus after migration. The cell movement was
analyzed manually by means of ImageJ, where the rela-
tive position of each cell in time was recorded and used
further for calculating the path and cell velocity. The
behavior of 4 representative cells for each experimental
system is plotted as a change of cell velocity as a func-
tion of time of observation. The data were normalized
to present a transmigration step at time 0 for all the
analyzed cells. Analyzed X and Y cell positions in pixels
(one pixel corresponds to 0.8 μm) were also used to plot
the cell path before and after transmigration through
the pore by means of Matlab.
A control experiment was performed to analyze cell
migration without coating of the membrane with cell
adhesion proteins. The cell velocity presented in Fig. 5
in the device with an uncoated membrane does not
change significantly during observation time and is in
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Fig. 5 Jurkat cell velocity change in time in the device with
uncoated membrane. Cell velocity does not change during time
of observation. Cell moves with a velocity close to flow velocity
of 3.3 mm/s
the range of the applied flow velocity of 3.3 mm/s.
The experiment was performed to check whether trans-
migration under shear flow will occur due to stimu-
lation with a chemoattractant. As no migrating cell
was observed in the movies we concluded that for
more effective migration a membrane coating must be
applied. All further experiments were thus performed
with a membrane coating with cell adhesion proteins.
Among adhesion receptors involved in migration
VLA4 plays a major role in the adhesion of leuko-
cytes to endothelial cells (Barreiro et al. 2002). VLA4
interacts with both fibronectin and VCAM-1 proteins
that are often used in transwell assays (Alon et al.
1995). Fibronectin is naturally present in the basement
membrane underlying endothelial cells (Hamann and
Engelhardt 2005). Moreover, it enhances cell adhesion
to the membrane due to integrin activation (Pankov
et al. 2002). However, the main ligand for VLA4 in-
tegrin is the VCAM-1 protein, which is one of the
major endothelial receptors that mediates leukocyte
rolling (Alon et al. 1995; Butcher and Picker 1996) and
adhesion to the vascular endothelium (Barreiro et al.
2002). Parallel experiments were run with a membrane
in the device coated with fibronectin and VCAM-1 to
test their effect on cell migration of Jurkat cells and
lymphocytes.
An example of Jurkat cell migration in the device
coated with fibronectin is shown in Fig. 6, presenting
changing cell velocity in time. The graph can be divided
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Fig. 6 Jurkat cell migration through the membrane coated with
fibronectin. The initial linear drop in cell velocity indicates the
adhesive interactions with the fibronectin on a membrane. The
short constant cell velocity region occurs due to adhesion to the
membrane before the migration through the pore. After transmi-
gration (a dashed line) the cell velocity drastically increases as the
cell is taken with a constant flow in the chemoattractant channel
where no adhesive interactions slow down the cell motion
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into three regions—linear decrease, short constant and
increase in cell velocity. The decrease in cell velocity
occurs due to chemoattractant sensing, which activates
the cell surface and results in the cell slowing down
and approaching the membrane. The cell velocity is
decreasing linearly, however no distinct rolling step was
observed. A very short region of constant cell velocity
can be observed just before the transmigration through
pores for the cells presented as diamonds and circles
in Fig. 6. During the time of constant cell velocity the
cell is further activated by the diffused chemoattrac-
tant and adheres to the membrane due to fibronectin-
integrin interactions. The cell is slowly crawling on the
membrane to reach a pore and transmigrates. After
transmigration, the cell moves with high velocity with
the flow in the chemoattractant channel, due to lack
of adhesive interactions with the membrane, illustrated
in the graph as a linear increase in cell velocity. The
cell velocity after transmigration is close to the flow
velocity.
In the separate experiment with VCAM-1 coated
membrane, we observed that VCAM-1 induced rolling
of Jurkat cells on the membrane, followed by adhe-
sion and transmigration through the membrane. The
change in velocity of Jurkat cells in time is shown in
Fig. 7. The graph can be divided into regions of a
linear decrease in velocity, a very short region of a
constant velocity and a linear increase in velocity. The
initial cell velocity slightly decreases in the observation
period due to sensing of the diffused chemoattractant.
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Fig. 7 Jurkat cell migration on the membrane coated with
VCAM-1. The initial linear decrease in velocity indicates the
rolling step, the cell velocity is further reduced during adhesion
step, when cell is crawling to reach the pore. After transmigration
(a dashed line) cell velocity rapidly increases when the cell joins
the flow in the other channel
As the cell is flowing close to the membrane the inter-
action between VCAM-1 and the cell surface receptors
occurs, resulting in a loose attachment of the cell to
the membrane. The cell is moving with an average of
150 μm/s which indicates a rolling step as it is much
lower than the flow velocity at the distance of 5 μm
from the wall (calculated to be 475 μm/s). The shear
flow in the channel detaches the cell allowing it to roll
on the surface. During rolling the cell surface becomes
activated and tight adhesion occurs due to strong in-
teractions between VCAM-1 and integrins on the cell
surface, which is presented as the short constant veloc-
ity. This constant velocity region, which lasted from 6 s
(diamonds) to 1 s (squares), represents the cell arrested
on the membrane and slowly moving towards the pore.
After transmigration through the pore (dashed line in
Fig. 7), similarly to the fibronectin experiment, the cell
velocity increases after reaching the chemoattractant
channel.
The last experiment prepared to validate the mi-
crofluidic device operation was performed with pu-
rified lymphocytes migrating on a surface coated with
VCAM-1. The movement of four cells was analyzed
and is plotted as cell velocity change in time in Fig. 8.
Two different cell behaviors can be observed in the
graph. Two cells (diamonds and circles in the graph)
behave like Jurkat cells on fibronectin surface, with a
linear decrease in the cell velocity followed by rapid ve-
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Fig. 8 Lymphocytes migration on the membrane coated with
VCAM-1. The four analyzed cells present different behavior
before transmigration, red (squares) and green (triangles) cells are
rolling, while blue (diamonds) and grey (circles) represent rapid
linear decrease in velocity when approaching the membrane.
After transmigration through the pore (a dashed line) the cell
velocity increases, as the cell starts moving in the chemoattractant
channel
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locity increase after transmigration. The other two cells
(triangles and squares) act as Jurkat cells on VCAM-
1 coated membrane. These two cells are rolling on
the surface with an average velocity of 110 μm/s and
280 μm/s for triangles and squares, respectively. After
transmigration, all four cells experience an increase in
cell velocity. No adhesive interactions occur between
lymphocyte and the surface after transmigration, thus
the observed high cell velocity.
In Fig. 9 the trajectories (in pixels) of the Jurkat cells
of Fig. 6 are shown with a color change according to
the cell velocity. The cells are moving in the direction
of flow; after adhesion to the membrane, they start
crawling to reach the nearest pore. Figure 9 also shows
the change in cell velocity before and after migration
through pores. All cells slow down approaching the
membrane; once they reach the membrane, they start
to slowly move in the direction of the nearest pore.
After migration their velocity increases when they join
the flow in the chemoattractant channel. Such behavior
of cells is mediated by adhesive interactions with the
substrate in response to chemoattractant activation.
Cell migration is a multistep process that starts with
an initial rolling step, which involves transient attach-
ment between leukocytes and ligands on endothelial
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Fig. 9 Jurkat cells movement on the surface coated with
fibronectin. The cells moving in the direction of flow slow down
when approaching the membrane, once they adhere they start
crawling to reach the nearest pore. After transmigration the cell
velocity increases as the cells reach the other channel
cells. In the proposed microfluidic migration device
the ligands naturally present on endothelial cells are
coated on the membrane surface. Near the membrane
rolling cells are exposed to chemoattractant solution
that serves as an activating molecule. The activation
of integrins on the leukocyte surface occurs within
seconds and leads to firm adhesion to the membrane
followed by transmigration directed by the chemoat-
tractant gradient (Roth et al. 1995). The described
device, enables studies of the migration process in real
time, with cell transmigration occuring as fast as in a
natural process.
During the experiments with coated membrane we
observed higher cell adhesion and migration at the end
of the channel. Due to the diffusing chemoattractant
cells were activated more significantly towards the end
of the channel. Jurkat cells were seen to strongly adhere
on the fibronectin surface, however no distinct rolling
step was observed. On the other hand, Jurkat cells were
rolling over long distances on the surface coated with
VCAM-1. The maximum velocity of a free flowing cell
in the device is around 1,500 μm/s, thus the 10 times
drop in cell velocity is considered a rolling velocity. The
rolling step was followed by firm adhesion and sub-
sequent transmigration through pores. These findings
are contrary to those presented by Alon et al. (1995)
where no rolling was observed in case of Jurkat cells on
VCAM-1. The average velocity of rolling Jurkat cells
is around 150 μm/s, the average velocity of the two
rolling lymphocytes is around 195 μm/s. The cell veloc-
ity of lymphocytes obtained by Campbell et al. (1998) is
100 μm/s, which is close to our results. The difference
might arise from manual analysis of our migration data,
different chemokines used for cells activation as well as
the system used for migration experiments.
Even though some purified lymphocytes were seen
to both roll and adhere to the surface coated with
VCAM-1, such behavior was not observed for all cells.
Lymphocytes were purified from the donors blood and
used in the experiments without further steps of syn-
chronization. Cells being in different stages of cell cycle
might respond differently to chemoattractant stimu-
lation, hence migrate without an initial rolling step.
Furthermore, lymphocytes purification has a yield of
around 60% with some other immune system cells also
present in the suspension, which may be activated in
different ways by chemoattractant and proteins on the
membrane. The average rolling velocity of lymphocytes
in the experiments was 195 μm/s, which is close to the
velocity obtained by Campbell et al. (1998), but far
from Alon et al. (1995). Alon et al. found that rolling
velocity of lymphocytes on VCAM-1 surface is around
5 μm/s for a shear stress of 1 dyn/cm2. Such a huge
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difference may occur due to different chemokines used
for stimulation of cells migration.
The control experiment performed in the device
without membrane coating revealed the importance of
cell adhesion molecules on cell migration. No cells were
seen to slow down and migrate through the membrane
with stimulation by chemoattractant only. Thus, we
conclude that for migration to occur under shear flow
conditions, cell adhesion proteins such as fibronectin
or VCAM-1 should be applied (Elices et al. 1990).
Both these proteins are naturally present in the blood
vessels—fibronectin in the basement membrane under-
lying endothelial cells and VCAM-1 apically overex-
pressed on endothelial cells during inflammation. The
VLA-4 integrin expressed on the leukocytes surface
can bind both these proteins using different mechanism,
which is advantageous in the natural process as the cell
during inflammation can adhere to both of these sub-
strates (Elices et al. 1990). Both proteins enhanced the
cell migration in the microfluidic device, however, their
effect was not the same on all migrating cells. Jurkat
cells and some lymphocytes experienced a rolling step
on the surface coated with VCAM-1. All cells were
at some point arrested on the membrane and started
crawling to reach the nearest pore, but the time of the
arrest step varied from cell to cell. Such a variation
could arise from difference in expression of proteins on
the cell surface or the vertical distance of the cell from
the membrane. We concluded that both fibronectin and
VCAM-1 proteins are useful for studying migration,
however, to investigate a multistep process it is advan-
tageous to use VCAM-1 as it enables a distinct rolling
step to be observed.
4 Conclusions
We have developed a novel microfluidic migration
device aiming at imitating physiological conditions of
cell transmigration. Combining the principles of a
Boyden chamber and a shear flow chamber assay in
one microfluidic device we created a system that closely
resembles the natural environment of migrating cells.
Due to physical separation of channels by a membrane
the cells must actively migrate towards a pore, similarly
to extravasation from blood vessels to underlying tis-
sue. Moreover, application of a continuous shear flow
promotes migration and maintains the concentration
gradient in time and space. Coating of both channel and
membrane imitates the 3D environment of migrating
cells. Furthermore, not only does the described device
allow for reduction in sample volume used but is also
inexpensive, easy to fabricate, disposable and amenable
for high throughput analysis.
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7.2 Concluding Remarks
A thorough understanding of leukocyte recruitment from the circulation to peripheral
tissue is important in many medical aspects. We developed an in vitro setup to study
immune cell transmigration in a three dimensional microenvironment. The system enables
studies of all steps involved in the cell migration process with potential application in basic
research and therapeutic drugs screening.
Currently, the device is based on microscopic detection, and the next step is to integrate
conductive polymer electrodes at the inlet (where cells are introduced) and outlets to
obtain a quantitative measure of the cell transmigration by electrochemical impedance
spectroscopy.
The physiological conditions of the microenvironment could be further improved by intro-
ducing a monolayer of endothelial cells on the membrane that separates the microfluidic
channels, and it would also be interesting to use a hydrogel as a model for the soft tissue
cells are migrating towards.
Chapter 8
Impedimetric Detection of
Cell Migration
8.1 Introduction
Cell migration is an essential feature of life, and the importance of this complex process was
broached in Chapter 7. Cell motility is influenced by many different factors in the blood
and the surroundings. Some cells are said to be intrinsically motile, whereas others need at
least a global stimulation with a chemoattractant to initiate movement [64]. That signal
could be introduced by a variety of proteins for instance extracellular matrix components,
chemokines or growth factors.
Wound healing is a classical example of a biological process, involving directional migra-
tion of cells. Traditionally, this type of cell migration assay was performed by physically
wounding cell monolayers in cell culture dishes with a razor blade [77]. Despite the simpli-
city of this method, physical scraping often damage cells near a wound edge, disrupting
biological activities. Moreover, the assay requires large volumes of cell culture medium
and additional reagents to examine biological activities, and is unfit for scaling up to-
wards high throughput screening. One way to resolve these shortcomings is by combining
novel micro- and polymer technologies to develop a new cell migration assay for studies
of wound healing.
The microfluidic technology is increasingly being explored in cell biology for cell sort-
ing [78], cell culture [79–82], and single cell analysis [83]. For cell culture applications
some of the more important benefits are a high degree of control of the near cell environ-
ment compared to the traditional large scale systems. This includes control of mechanical
impact, control of chemical environment by controlled addition and removal of factors,
and tailored cell culture substrates by chemical surface engineering and micromachin-
ing. Other typical advantages of downscaling are reduced sample consumption, increased
throughput and reduced cost. Combined with the option to adjust the conditions over
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Figure 8.1: Schematic representation of microelectrode design; conductive polymer micro-
electrode pairs were designed with a width of 20 µm and placed 100 µm apart.
time the spatio-temporal control enables microfluidics to approach in vivo scenery.
This chapter presents an overview of the preliminary1 work on an on-chip cell migration
assay. An all polymer microfluidic device with conductive polymer microelectrodes was
developed for real time and label free electrochemical detection of directional cell migra-
tion. By exploiting laminar fluid flow conditions, a precisely controlled wound edge was
formed of a cell monolayer in the main channel of the chip without damaging the cells.
The microfluidic device enables quantitative and qualitative studies of cell migration by
electrochemical impedance spectroscopy and video time lapse microscopy.
8.2 Microfluidic System
An all polymer microfluidic device was designed with two sets of conductive polymer
microelectrodes for impedimetric real time sensing of migrating cells. The microdevice
was fabricated in Topas® and PEDOT:TsO by injection molding [11] and standard pho-
tolitographic processing techniques in the Danchip Cleanroom (Technical University of
Denmark) as described in Chapter 6 [13].
The system features three inlets, converging into a single main channel as depicted in
Figure 8.1. Conductive polymer microelectrode pairs were designed with a width of 20µm,
placed 100 µm apart. Taking advantage of the microfluidic flow conditions, laminar flow
streams were used to control the distribution of human cells in the microchannel. To
1Experiments were partly performed by master student Louise Laursen, supervised by the author of
the thesis.
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Figure 8.2: Visualization of laminar flow using color, and fluorescence intensity profile near
the inlet (gray) and in the middle of the main channel (blue), indicating the formation of
a two dimensional fluid phase gradient.
confirm the formation of laminar flow in microchannels, coloring was introduced from
different inlet reservoirs, and microscopy was used to visualize the laminar flow. The
color flowed with very faint diffusion, and the three streamlines showed clear boundaries
(Figure 8.2).
At laminar flow conditions, interfacing streamlines mix by diffusion. A two dimensional
fluid phase gradient was established in the main channel of the microfluidic device by
introducing a solution of fluorescently labelled biomolecules at separate inlets. The ac-
quired microscopy images were analyzed in Matlab and the intensity profiles were found
to correlate with a simulation in Comsol Multiphysics (data not shown).
The changes in intensity in the width of the channel illustrated changes in the steepness
of a concentration gradient. As illustrated in Figure 8.2, the concentration gradient was
very steep near the inlets due to little mixing. The slope of the intensity profile decreased
continuously along the length of the channel as particles were mixed by diffusion.
8.3 Wound Healing Assay
Healthy human cells were seeded directly in the microfluidic channel of the chip, and
allowed to attach and spread on the substrate and acclimatize over night. A wound edge
was formed by injecting cell medium and a trypsin-EDTA solution from the three inlets,
thereby selectively treating the cell monolayer. Based on the formation of laminar flow
in the microchannels, only cells in contact with trypsin-EDTA were detached from the
substrate, while untreated cells remained intact and formed a clear wound edge. The
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Figure 8.3: Patterning processes to create wound edges for the confluent monolayer of cells
in microchannel. (a) Schematic illustration of experimental processes, modified from [84].
(b) Five hours post seeding, (c) confluent cell monolayer, and (c) the formed wound edge
after treatment with trypsin-EDTA. Channel width is 1mm.
patterning procedure is illustrated in Figure 8.3, together with phase contrast microscopy
images of the main channel of the device at different steps in the process.
For these preliminary experiments, human foreskin fibroblast cells were employed, and the
changes in the distribution of cells in the main channel before and after partial digestion
of the cell monolayer was evident. We have examined the cell viability of other established
cell lines (HeLa, HT1080, and HUVEC) and primary dendritic cells in the microdevice
for potential application in the future. The establishment of a wound edge by selective
digestion of the cell monolayer has previously been reported [84,85].
Following wound edge formation, random cell migration was allowed to proceed in the
microchannel for several days, and the fibroblast cells were observed to migrate across the
wound edge toward the cell denuded areas (Figure 8.4). Human foreskin fibroblast cells
are quite immobile, hence not an ideal choice for cell migration studies, however, the cells
are very robust and easy to handle for preliminary experiments. Figure 8.4(b) and (c)
display phase contrast microscopy images captured 17 and 41 hours after partial digestion
of cell monolayer, respectively. After two days, a noticeable random cell migration across
the wound edge was observed and the distribution of cells appeared more evenly in the
microfluidic channel.
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Based on these preliminary findings, the microelectrode design was optimized, allowing
for impedimetric detection of cell migration. Figures 8.5(a) and (b) display phase contrast
microscopy images of the main channel in the microfluidic device before and immediately
after selective digestion of the cell monolayer, featuring two pairs of conductive polymer
microelectrodes for electrical detection of cell migration. For these preliminary experi-
ments, impedance measurements were performed using only one pair of microelectrodes.
Cell migration was then allowed to proceed for several hours, monitored by video time
lapse microscopy and electrochemical impedance spectroscopy.
Time lapse films illustrated the motility of human foreskin fibroblast cells in the micro-
fluidic channel of the chip, and snapshots captured at different time points (several hours
into the experiment) during an assay are shown in Figures 8.5(c)-(f). The change in abso-
lute impedance in response to cell migration is depicted in Figure 8.6. Preliminary results
indicate that cells migrate across the wound edge toward cell denuded areas, reaching the
first pair of conductive polymer microelectrodes after a couple of hours (the time scale
is cell type dependent). This is reflected by a drastic rise in the impedance at 2 -8 hours,
because healthy cells act as an insulating layer on the electrode surface [45] by blocking
the diffusion of ions to the electrodes. Subsequently, the absolute impedance arrives at
a plateau, indicating that the electrode is completely covered with a monolayer of cells.
These findings correlate with previously published data [45,46].
The next step is to measure the impedance on both electrode pairs in parallel to quantify
the cell migration, and to direct the cell migration by establishing a two dimensional
chemotactic gradient in the main channel of the chip. Based on our findings, we will
re-evaluate the design of the microelectrodes and microfluidic channels, and eventually
continue directional cell migration studies with another cell type.
Figure 8.4: Phase contrast microscopy images captured (a) immediately after selective
digestion of cell monolayer, (b) 17 hours and (c) 41 hours after after wound edge formation.
Cells migrate across the wound edge towards cell denuded areas (from left to right).
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Figure 8.5: Preliminary result. Cell migration in main channel of microdevice; (a) phase
contrast microscopy image before selective digestion, (b) phase contrast microscopy image
immediately after selective digestion, and (c)-(f) phase contrast microscopy snapshots of
motile human foreskin fibroblast cells in the microfluidic channel of the chip. Cells migrate
towards the conductive polymer microelectrodes, and cells in contact with an electrode
are detected by electrochemical impedance spectroscopy.
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Figure 8.6: Preliminary result. Electrochemical detection of cell migration in microdevice.
The absolute impedance was measured at a frequency of 2Hz and baseline was subtracted.
8.4 Concluding Remarks
In summary, we have developed a prototype of an all polymer microfluidic device for im-
pedimetric cell migration studies of wound healing. The preliminary data suggest that cells
migrate across the wound edge towards cell denuded areas. Cell migration was detected
by video time lapse microscopy and electrochemical impedance spectroscopy.
In the current experimental setup, cells migrate randomly in the microfluidic channel
of the chip. With time, a two dimensional chemotactic or haptotactic gradient should be
established in the main channel of the device to enable studies of directional cell migration.
It is also essential to measure the impedance on both microelectrode pairs, in order to
extract any quantitative data from the experiment. In general, further experimentation is
required before any conclusions can be drawn whether or not further device modifications
have to be implemented.
The main features of the presented cell migration assay are the easy and delicate handling
of cells, combined with visual and electrical detection of migration. Materials were selected
with care. To keep the costs and environmental footprint low the entire biosensor was
fabricated in plastic; featuring microfluidic channels and an electrode system fabricated
from conductive polymers.

Chapter 9
Project Review
The objective of the PhD project was to develop an all plastic biosensor for medical
diagnosis of acute viral disease and with potential for miniaturization into a point of care
system.
The goal was met and documented in peer reviewed journals. Review, assessments, oppor-
tunities for improvement or future work, and general discussions with respect to each of
the solutions and the project in general are provided below.
9.1 Aptamer Based Biosenor
A simple, accurate and fast alternative to the commercially available rapid influenza diag-
nostic tests was developed. In the wake of the 2009 flu pandemic, there has been a strong
interest in rapid influenza tests, but these tests are inaccurate and lack sensitivity. Electro-
chemical impedance spectroscopy is a very sensitive technique for label free biosensing in
real time, and the platform is acknowledged for its possibility of miniaturization and use
in point of care diagnostic devices.
A plastic microfluidic device, featuring conductive polymer microelectrodes was fabrica-
ted by injection molding and out of cleanroom processing techniques. This microelectrode
patterning procedure was chosen for economic reasons and agarose stamping is highly suit-
able for prototyping and low throughput. Since absolute reproducibility of microelectrodes
was unattainable, other fabrication methods should be considered for future large scale
production of a finalized chip.
High specificity of the polymer biosensor was achieved by functionalization; aptamers
with high affinity for influenza virus were covalently linked to the conductive polymer
microelectrode surface to selectively fish out virions from an introduced fluid.
The polymer biosensor was exploited for label free, and real time detection of influenza
A virus particles. Based on changes in the impedance when virions were captured by
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immobilized aptamer probes, clinically relevant concentrations of influenza virus in saliva
specimens were directly measured. The disposable microfluidic system is highly sensitive,
highly specific, highly stable, and with a very attractive response time of less than fifteen
minutes. We used influenza A virus in saliva specimens as an example to demonstrate the
usability of the biosensor, and the foundation for a competitive diagnostic tool is at hand.
This could become an alternative to current diagnostic techniques.
The biosensing platform was also with success adapted to different tasks and tested against
DNA and antibiotics. Throughout the experiments, the sensors demonstrated high sensi-
tivity and were able to detect very low analyte concentrations in both buffered solutions
and milk.
Although the biosensor showed promising results, the microdevice could be improved in
many aspects: The manufacturing procedure is inappropriate for large scale production,
and improved control of the conductive polymer - which is very sensitive to environmental
factors - is another necessity for the biosensor to perform well under non laboratory condi-
tions. With improvements, the system has the potential for several marketable applications
in health care and other industries.
9.2 Nanowire Based Biosensor
Most recently, we initiated work on conductive polymer nanowires in collaboration with
the NaBIS group at DTU Nanotech, employing a novel procedure for fast and cost effective
fabrication of nanowires. The goal is to explore the sensitivity of these tiny sensors for
impedance based characterization of single cells and detection of single virus particles in
body fluids. We are at the stage of learning by doing. So far, we have electrically measured
the adhesion of single cells on conductive polymer nanowires in a microdevice. Nanowires
could represent a new future in point of care medicine and diagnostics, using minute sample
volume and delivering an accurate response within minutes.
9.3 Cell Based Biosensor
An all polymer microfluidic biosensing system for real time detection of acute viral disease
in human cell culture was developed. A plastic microfluidic device, featuring conductive
polymer microelectrodes was designed and fabricated by injection molding and standard
photolitographic processing techniques in cleanroom. This procedure ensured complete
reproducibility of all device components, including microelectrodes. During the design
process, the cell compatibility of different polymer materials was evaluated by culturing
human cells for a full week, and cell viability was also surveyed in microchips. Both sep-
arately and united, the materials demonstrated excellent cell compatibility, and human
fibroblast cells behaved naturally in the microenvironment for studies of more than a week
duration.
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The polymer biosensor was exploited for label free and real time electrochemical detection
of infectious agents in human cell culture - human fibroblast cells were infected with
human cytomegalovirus. Employing electrochemical impedance spectroscopy, we could
measure the immediate cell response to virus, and detect an infection within three hours,
which are several hours before the cytopathic effect is apparent with conventional imaging
techniques. Atomic force microscopy and scanning ion conductance microscopy imaging
consolidated the electrochemical measurements by demonstrating early induced changes
in cell morphology and apparent programmed cell death.
In conclusion, we developed an impedimetric cell based biosensor for fast and sensitive
detection of infectious agents. The sensing platform presents a low cost and competitive
alternative to viral culture and other traditional techniques for diagnosis of acute viral
disease, and also has the makings of a success in other fields of medicine.
9.4 Cell Migration
Parallel to the main topics of the PhD project, I have been engaged in design and de-
velopment of microfluidic systems for cell migration studies. This is a fascinating field of
research, seeking answers to fundamental questions, as opposed to the more application
oriented experimental work associated with biosensors.
The development of new drug therapies relies heavily on cell migration studies in vitro.
Many years of extensive research has improved the comprehension of immune surveillance
and host defence, however there is a shortage of cell migration assays incorporating this
knowledge. We developed a novel cell migration assay based on the principles of two
conventional systems, yet imitating the natural environment of migrating cells and meeting
the requirements for a new transmigration assay.
In another project, we focused on developing a plastic microfluidic system for quantitative
and qualitative studies of directional cell migration. Preliminary data indicate that the
biosensor - with some adjustments - is operable for visual and electrical detection of cell
migration.
9.5 Summary
Plastic sensing platforms for virus detection were developed and evaluated during the PhD
project. The microsystems were fabricated solely from polymers, allowing the potential for
upscaling for mass production of portable diagnostic point of care devices.

Chapter 10
Conclusion and Perspectives
The presented work demonstrates the development and usability of all polymer micro-
fluidic devices for biosensing applications in medicine and diagnostics. An all polymer
microfluidic device formed the basis of the work, and during the project the biosensing
unit and microfluidic channel design were continuously modified for improved sensitivity
and specificity in accordance with the requirements for specific use.
Different microfluidic sensing platforms for medicine and diagnostics were presented in
this thesis. The main focus of the PhD project was development of an impedimetric sensor
for diagnosis of acute viral disease, and two sensing platforms have been presented; a cell
based biosensor and an aptamer based biosensor. Microfluidic devices for studies of cell
migration were developed in parallel projects.
The list below points out the three main results accomplished during this PhD project.
Aptamer based biosensor
Detection of clinically relevant concentrations of influenza virus in saliva within minutes.
Competitive to polymerase chain reaction and immunology based assays.
Cell based biosensor
Identification of virus infection in cell culture within few hours.
Competitive to conventional cell culture.
Cell Migration in Microfluidic Device
Microfluidic device imitating the physiological conditions of cell transmigration.
Competitive to conventional Boyden chamber and shear flow chamber assay.
With some modifications and clinical studies, the diagnostic sensors have the potential to
replace conventional assays for virus identification, or be included in the routine screening
program in combination with the established assays. Basic research and development of
new drug therapies rely heavily on studies of cell migration in in vitro systems. The
presented devices represent a significant improvement compared to the currently available
experimental platforms.
88 Conclusion and Perspectives
Unlike the traditional diagnostic techniques, simple and disposable impedance based biosen-
sors produce a sensitive and accurate response in minutes rather than hours or days, and
the systems have the makings of miniaturization into cheap point of care devices for use
in third world countries to identify and diagnose infectious diseases.
In general, electrochemical sensors have played an important role in the move towards
simplified testing. The electrical devices are extremely useful for delivering medicinal and
diagnostic information in a simple, fast, low cost and accurate fashion.
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